US20020115740A1 - Hydrogels and hydrogel arrays made from reactive prepolymers crosslinked by [2 + 2] cycloaddition - Google Patents
Hydrogels and hydrogel arrays made from reactive prepolymers crosslinked by [2 + 2] cycloaddition Download PDFInfo
- Publication number
- US20020115740A1 US20020115740A1 US10/131,426 US13142602A US2002115740A1 US 20020115740 A1 US20020115740 A1 US 20020115740A1 US 13142602 A US13142602 A US 13142602A US 2002115740 A1 US2002115740 A1 US 2002115740A1
- Authority
- US
- United States
- Prior art keywords
- hydrogel
- photocyclizable
- monomer
- reactive prepolymer
- monomers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 *C(C)CC(CC)C(N)=O Chemical compound *C(C)CC(CC)C(N)=O 0.000 description 2
- BWUZGCIOLNYNCX-KOYVTHSTSA-N C/C=C\C.C/C=C\C.CC(C)C(C)C(C)C(C)C Chemical compound C/C=C\C.C/C=C\C.CC(C)C(C)C(C)C(C)C BWUZGCIOLNYNCX-KOYVTHSTSA-N 0.000 description 1
- YOUZDUHNWCWOJM-KOYVTHSTSA-N C/C=C\C.C/C=C\C.CC1C(C)C(C)C1C Chemical compound C/C=C\C.C/C=C\C.CC1C(C)C(C)C1C YOUZDUHNWCWOJM-KOYVTHSTSA-N 0.000 description 1
- JPNZNLBTIRHZKL-UHFFFAOYSA-N C=C(C)C(=O)OCC1CO1.C=CC(=O)O.C=CC(=O)OCC(O)COC(=O)C(=C)C Chemical compound C=C(C)C(=O)OCC1CO1.C=CC(=O)O.C=CC(=O)OCC(O)COC(=O)C(=C)C JPNZNLBTIRHZKL-UHFFFAOYSA-N 0.000 description 1
- NAZFGHLLJRSQEE-UHFFFAOYSA-N C=CC(=O)OCCCCCCN1C(=O)C(C)=C(C)C1=O Chemical compound C=CC(=O)OCCCCCCN1C(=O)C(C)=C(C)C1=O NAZFGHLLJRSQEE-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00614—Delimitation of the attachment areas
- B01J2219/00621—Delimitation of the attachment areas by physical means, e.g. trenches, raised areas
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00632—Introduction of reactive groups to the surface
- B01J2219/00637—Introduction of reactive groups to the surface by coating it with another layer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00639—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium
- B01J2219/00644—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium the porous medium being present in discrete locations, e.g. gel pads
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31504—Composite [nonstructural laminate]
- Y10T428/31725—Of polyamide
Definitions
- Acrylamide (CH 2 ⁇ CHC(O)NH 2 ; C.A.S. 79-06-1; also known as acrylamide monomer, acrylic amide, propenamide, and 2-propenamide) is an odorless, free-flowing white crystalline substance that may be polymerized to form polyacrylamides.
- the resulting high molecular weight polymers have a variety of uses and further can be modified to optimize nonionic, anionic, or cationic properties for specified uses.
- Polyacrylamide hydrogels are used as molecular sieves for the separation of nucleic acids, proteins, peptides, oligonucleotides, polynucleotides, and other biological materials. They are also used as binding layers for biological materials. When used as binding layers, the gels currently are produced as thin sheets or slabs, typically by depositing a solution of acrylamide monomer, a crosslinker such methylene bisacrylamide, and an initiator such as N,N,N′,N′-tetramethylethylendiamine (TEMED) between two glass surfaces (e.g., glass plates or microscope slides) using a spacer to obtain the desired thickness of polyacrylamide.
- TEMED N,N,N′,N′-tetramethylethylendiamine
- the acrylamide polymerization solution is a 4-5% solution (acrylamide/bisacrylamide 19/1) in water/glycerol, with a nominal amount of initiator.
- the acrylamide is chain-polymerized and crosslinked by radical initiation from ultraviolet (UV) radiation (e.g., 254 nm for about 15 minutes) or heat (e.g., about 400° C.).
- UV radiation e.g., 254 nm for about 15 minutes
- heat e.g., about 400° C.
- the reaction time of the acrylamide is excessively long (e.g., typically from about 15 to about 90 minutes at a short wavelength of about 254 nm), making the UV polymerization and crosslinking step incompatible with standard imaging equipment such as mask aligners and photoprinters.
- the acrylamide monomer is a neurotoxin and a carcinogen which makes coating, handling, and waste disposal of the material hazardous and expensive.
- Polyacrylamide hydrogels that incorporate [2+2] photoreactive sites are disclosed.
- the hydrogels are especially useful for microarray formation and are made from prepolymers, including polyacrylamide reactive prepolymers.
- the photoreactive sites allow use of [2+2] cycloaddition reactions to not only crosslink the polyacrylamide reactive prepolymers forming the hydrogel, but also for later attachment of any other molecules incorporating additional photoreactive sites.
- the disclosed hydrogels provide a more uniform pore size, likely resulting from an improved control of crosslinking, making them preferable for use with DNA based probes. Additionally, because higher viscosity prepolymers, as opposed to low viscosity monomer solutions, are used to form the arrays, manufacturing is simplified.
- FIG. 1 depicts a DMI based polyacrylamide reactive prepolymer formed by a “one-step” process.
- the polyacrylamide reactive prepolymer (PRP) was formed by thermally polymerizing monomers of acrylamide and N-(6-acryloylhexyl)-2,3-dimethylmaleimide. Because N-(6-acryloylhexyl)-2,3-dimethylmaleimide is “bifunctional,” (having both a polymerizable functionality and a [2+2] photoreactive site in a single molecule) it forms a PRP directly upon copolymerization with acrylamide.
- the PRP Upon irradiation with ultraviolet light, the PRP is crosslinked to form a hydrogel by cycloaddition at the [2+2] photoreactive sites.
- Substituents x and y can be varied between 1 and 50.
- the wavy line ( ⁇ ) between oxygen and nitrogen represents the hexyl spacer group.
- the dashed bonds (———) indicate attachment points for additional monomers.
- FIG. 2 depicts a “two-step” reaction scheme for reactive prepolymer formation.
- a copolymer of acrylamide and acrylic acid is formed.
- the copolymer is treated with a [2+2] photoreactive compound, such as acryloyl chloride.
- the acrylic acid monomer then condenses with the acryloyl chloride to give a PRP with an acrylate provided [2+2] photoreactive site.
- Substituents x and y can be varied between 1 and 50. The dashed bonds indicate attachment points for additional monomers.
- FIG. 3 depicts a Glycidyl Methacrylate Based PRP resulting from a two-step process in which a copolymer of acrylamide and acrylic acid is reacted with glycidyl methacrylate.
- An acrylate provided [2+2] photoreactive site results.
- [2+2] photoreactive sites provided by acrylate groups will not photocyclize with themselves, but will undergo undesirable chain-type polymerization if irradiated with UV light
- a mixed hydrogel is formed by ultraviolet exposure in the presence of a DMI based PRP.
- an additional crosslinking agent can be used to form a hydrogel from the acrylate based PRP.
- Substituents x and y can be varied between 1 and 50. The dashed bonds indicate attachment points for additional monomers.
- Hydrogels suitable for forming microarrays and continuous films to which probes may be attached by [2+2] photocycloaddition chemistry are described.
- the arrays or films are formed by first synthesizing a reactive prepolymer that incorporates [2+2] photocyclizable sites.
- a thin layer of prepolymer solution is then placed on a solid support and exposed to ultraviolet light. If microarrays are desired, the hydrogel layer is selectively exposed to ultraviolet light.
- a portion of the [2+2] photocyclizable sites exposed to the light undergoes cyclization to crosslink the reactive prepolymer, thus forming a hydrogel.
- the uncyclized reactive prepolymer is then washed away with an aqueous solution. Unlike the reactive prepolymer, the crosslinked hydrogel is not water-soluble.
- a continuous hydrogel film or microarray of hydrogel sites attached to the solid support results.
- Probes or other molecules containing [2+2] photoreactive sites may undergo cycloaddition with the hydrogel through further UV exposure. Sufficient [2+2] photoreactive sites are incorporated into the reactive prepolymer to crosslink the polymer to form the hydrogel and to remain available for later probe and other molecule attachment.
- the hydrogel pattern results from selective irradiation with ultraviolet light.
- Selective irradiation may be accomplished in multiple ways known to those of skill in the art. Preferable methods include (1) using an opaque mask to shield portions of the reactive prepolymer from ultraviolet exposure and (2) using a laser beam to only irradiate selected positions on the reactive prepolymer. Either method results in only selected portions of the reactive polymer being crosslinked. The uncrosslinked reactive polymer can then be removed to leave the array grid on the support.
- Monomers are the individual molecular units that are repeated to form polymers. Multiple monomers covalently attached form the backbone of a polymer. Polymers that are made from at least two different monomer units are referred to as copolymers. Polymerizing or copolymerizing describes the process by which multiple monomers are covalently linked to form polymers or copolymers, respectively. A discussion of polymers and monomers from which they are made may be found in Stevens, Polymer Chemistry: An Introduction , 3 rd ed., Oxford University Press, 1999. The preferred embodiments rely on three general classes of monomers to form reactive prepolymers.
- the monomers used in the preferred embodiments may be covalently attached by chain-type polymerization chemistry to form the backbone of the reactive prepolymer. Thus, these monomers are “polymerizable.”
- Chain-type polymerization is a polymerization reaction that is radical initiated.
- An energetic radical is formed in the presence of the monomers, which then join to form a polymer.
- Many methods of radical initiation are known, but most rely on thermal or light energy to generate the reactive radicals.
- thermal radical initiation is most preferred to form a polymer backbone incorporating acrylamide first monomers.
- preferred initiators include N,N,N′, N′-tetramethylethylendiamine (TEMED) and benzophenones.
- Preferable thermal initiators include peroxides, such as benzoyl peroxide. A chain-type polymerization reaction is depicted below.
- a monomer In order to undergo chain-type polymerization, a monomer must have “polymerizable functionality,” as provided by the olefins in the butylenes depicted above. During this butylene polymerization, for example, the unsaturated monomers covalently bond to form a saturated polybutylene polymer. The monomers are covalently attached through their polymerizable groups.
- the first type of monomer is preferably water-soluble and polymerizable.
- First monomers may be copolymerized by chain-type methods with other polymerizable monomers and impart hydrophilicity to the resultant copolymer. After polymerization, the first monomers are covalently bonded to themselves or other polymerizable monomers. They are also resistant to [2+2] cyclization reactions as described below. By cyclization resistant, it is meant that when heated or exposed to ultraviolet light, first monomers will preferentially undergo chain-type polymerization in relation to [2+2] cyclization.
- first monomers that undergo chain-type radical polymerization, resist [2+2] photocyclization, and solubilize in water are preferred first monomers.
- preferred first monomers include acrylamide, hydroxyethyl acrylate, vinyl pyridine, acrylic acid, methacrylic acid, and vinyl pyrrolidone, or mixtures thereof. Most preferred is acrylamide.
- the second type of monomer may be copolymerized by chain-type methods with other polymerizable monomers and includes a heteroatom (e.g. oxygen, nitrogen, sulfur, phosphorous). After copolymerization, the heteroatom may be used to covalently attach the second monomer to a [2+2] photocyclizable compound by a condensation reaction.
- a heteroatom e.g. oxygen, nitrogen, sulfur, phosphorous
- a condensation reaction occurs when two molecules are covalently joined through a non-radical pathway.
- the condensation of acrylic acid with glycidyl methacrylate is shown below.
- the oxygen heteroatom of acrylic acid opens the epoxide ring of glycidyl acrylate to form a covalent bond.
- Preferred second monomers can be any monomer that is polymerizable and has a heteroatom suitable for bonding with a compound having a [2+2] photoreactive site, as described below. More preferred second monomers include acrylic acid, glycidyl methacrylate, and methacrylic acid, or mixtures thereof. Acrylic acid is most preferred.
- Preferable [2+2] photocyclizable compounds include any compound incorporating a [2+2] photoreactive site that can undergo a condensation reaction with a second monomer. More preferred [2+2] photocyclizable compounds include glycidyl methacrylate, acrylic acid, hydroxyethyl acrylate, hydroxypropyl acrylate, and acryloyl halides, or mixtures thereof.
- the third type of monomers used to form reactive prepolymers includes both polymerizable functionality and [2+2] photoreactive sites in a single monomer.
- bifunctional monomers may be formed.
- bifunctional monomers form reactive prepolymers without requiring further incorporation of [2+2] photocyclizable compounds.
- bifunctional monomers are thermally copolymerized with a first monomer and then exposed to ultraviolet light to crosslink a portion of the [2+2] photoreactive sites to form a hydrogel.
- Preferable bifunctional monomers incorporate vinyl and dimethylmaleimide or cinnamate groups. Most preferred are N-(6-acryloylhexyl)-2,3-dimethylmaleimide (as shown below) and vinyl cinnamate.
- [2+2] photoreactive sites can undergo [2+2] photocycloaddition and are therefore [2+2] photocyclizable.
- [2+2] photocyclizable monomers are preferably any monomer unit that includes a [2+2] photoreactive site and a polymerizable site. Therefore, [2+2] photocyclizable monomers can be either bifunctional, like DMI, or made through condensation of a polymerizable compound with a [2+2] photocyclizable compound.
- a monomer or compound incorporating a [2+2] photoreactive site can undergo [2+2] cycloaddition with other monomers or compounds that possess a [2+2] photoreactive site. If a monomer or compound incorporating a [2+2] photoreactive site is irradiated with ultraviolet light, the [2+2] reactive portion of the molecule will preferentially undergo cycloaddition or “cyclize” with other [2+2] photoreactive sites, instead of undergoing chain-type polymerization.
- polymerizable sites have a greater electron density and are less sterically hindered than [2+2] photoreactive sites.
- second monomers and [2+2] photocyclizable compounds serve different chemical functions in the present embodiments, some molecules can provide either functionality depending on reaction order. For example, if acrylamide is copolymerized with acrylic acid and then condensed with glycidyl methacrylate, acrylic acid provides second monomer functionality and glycidyl methacrylate provides [2+2] photocyclizable compound functionality. Alternatively, if acrylamide is copolymerized with glycidyl methacrylate and then condensed with acrylic acid, glycidyl methacrylate provides second monomer functionality and acrylic acid provides [2+2] photocyclizable compound functionality.
- reaction order can determine whether a compound serves as a second monomer or a [2+2] photoreactive compound during two-step reactive prepolymer synthesis.
- [2+2] cyclization or cycloaddition is a light-induced reaction between two photoreactive sites, at least one of which is electronically excited.
- [2+2] cycloaddition reactions can proceed with high efficiency. While it is chemical convention to write cycloaddition centers in brackets, such as “[2+2]” or “[4+2],” the brackets were omitted from the claims to prevent confusion with the patent convention of deleting bracketed material. Hence, in the claims “[2+2]” is written as “2+2.”
- cyclization is of the [2+2] variety, wherein two carbon-carbon or a carbon-carbon and a carbon-heteroatom single bond are formed in a single step.
- the [2+2] cycloaddition involves addition of a 2 ⁇ -component of a double bond to the 2 ⁇ -component of a second double bond, as shown below.
- reaction may proceed by way of a 2 ⁇ -component of triple bonds. Under the rules of orbital symmetry, such [2+2] cycloadditions are thermally forbidden, but photochemically allowed. Such reactions typically proceed with a high degree of stereospecificity and regiospecificity.
- Photochemical [2+2] cycloaddition of monomers on opposing copolymer chains results in crosslinking of the copolymer backbones.
- [2+2] photocyclizable monomers can cyclize with other molecules, such as DNA probes, which incorporate [2+2] photoreactive sites. In this manner, other molecules may be attached to the preferred hydrogels.
- the additional [2+2] cyclizable molecules may be cyclized with the monomers during or after the cyclization reaction that crosslinks the monomers to form the hydrogel.
- the reactive prepolymer may be cyclized to a solid support, such as glass or plastic, which incorporates [2+2] photoreactive sites.
- Preferred [2+2] cycloadditions include those between two carbon-carbon double bonds to form cyclobutanes and those between alkenes and carbonyl groups to form oxetanes. Cycloadditions between two alkenes to form cyclobutanes can be carried out by photo-sensitization with mercury or directly with short wavelength light, as described in Yamazaki et al., J. Am. Chem. Soc., 91, 520 (1969). The reaction works particularly well with electron-deficient double bonds because electron-poor olefins are less likely to undergo undesirable side reactions.
- Photoreactive sites are defined as chemical bonds capable of undergoing [2+2] cycloaddition (cyclization) to form a ring structure when exposed to light of an appropriate wavelength. Photoreactive sites can yield homologous linking, where a monomer or other molecule photoreactive site cyclizes with a monomer or other molecule photoreactive site having the same chemical structure, or for heterologous linking, where a monomer or other molecule photoreactive site cyclizes with a monomer or other molecule photoreactive site having a different chemical structure.
- DMI and vinyl cinnamate [2+2] photoreactive sites can cyclize with themselves, each other, or acrylate provided [2+2] photoreactive sites. Unlike the photoreactive sites of DMI and vinyl cinnamate, however, acrylate provided [2+2] photoreactive sites do not undergo [2+2] photocycloaddition with themselves. Preferred homologous linking occurs between dimethyl maleimide (DMI) photoreactive sites, while preferred heterologous linking occurs between acrylate and DMI photoreactive sites.
- DMI dimethyl maleimide
- heterologous linking occurs between acrylate and DMI photoreactive sites.
- a detailed discussion of photoreactive sites may be found in Guillet, Polymer Photophysics and Photochemistry , Ch. 12 (Cambridge University Press: Cambridge, London). Generally, double bonds that are not part of a highly conjugated system (e.g. benzene will not work) are preferred. Sterically-hindered, electron deficient double bonds, such as found in maleimi
- maleimide/N-hydroxysuccinimide (NHS) ester derivatives include 3-maleimidoproprionic acid hydroxysuccinimide ester; 3-maleimidobenzoic acid N-hydroxy succinimide; N-succinimidyl 4-malimidobutyrate; N-succinimidyl 6-maleimidocaproate; N-succinimidyl 8-maleimidocaprylate; N-succinimidyl 11-maleimidoundecaoate.
- ALDRICH Milwaukee, Wis
- Crosslinking of the [2+2] photoreactive sites of the photocyclizable monomers in the reactive prepolymer is most preferably done with ultraviolet irradiation.
- a photosensitiser may be added to the reactive prepolymer to increase the efficiency of the cycloaddition reaction.
- Preferred photosensitisers include water-soluble quinones and xanthones, including anthroquinone, thioxanthone, sulfonic acid quinone, benzoin ethers, acetophenones, benzoyl oximes, acylphosphines, benzophenones, and TEMED (N,N,N′,N′-tetramethylethylendiamine).
- Anthroquinone-2-sulfonic acid is most preferred and is available from ALDRICH, Milwaukee, Wis.
- Irradiation is preferably carried out between 22 and 300° C.
- the reactive prepolymer is irradiated with ultraviolet light for preferably between 10 and 100 seconds, most preferably for about 30 seconds. Longer irradiation times result in thicker hydrogels, while shorter irradiation times yield thinner hydrogels.
- Useful hydrogels are preferably from about 2 nanometers to about 5 micrometers in thickness, more preferably from about 2 nanometers to about 100 nanometers in thickness, and most preferably from about 2 nanometers to about 50 nanometers in thickness. Thickness is defined as the dimension perpendicular to the support.
- irradiation may be carried out with any device capable of producing light at the preferred wavelengths
- a photolithography tool such as a metal halide lamp equipped Calibre ORC, available from Mentor Graphics (Wilsonville, Oreg.), is most preferred.
- a microarray it is preferable to selectively crosslink only a portion of the reactive prepolymer present on the solid support, thus forming a pattern or grid of separate hydrogel locations.
- One method of accomplishing this goal is after application of the reactive prepolymer to the support, the reactive prepolymer is covered with a mask having only a portion of its surface transparent to the irradiation light. When the mask is then irradiated, only the portion exposed to the light crosslinks to form a hydrogel. The uncrosslinked reactive polymer is then removed, preferably with aqueous solutions. In this fashion, the pattern of the mask is transferred to the hydrogel microarray. See Sze, VLSI Technology , McGraw-Hill (1983).
- Patterned hydrogel microarrays can also be formed on the support by using an ultraviolet laser to only irradiate the portions of the reactive prepolymer where a hydrogel is desired. See U.S. Pat. No. 4,719,615. After this targeted irradiation, the excess reactive polymer is removed, leaving a microarray of individual hydrogel locations.
- the hydrogel locations may preferably be arranged in rows and columns.
- each location of hydrogel extends from about 2 nanometers to about 5 microns, more preferably from about 2 nanometers to about 100 nanometers, and most preferably from about 2 nanometers to about 50 nanometers in the direction perpendicular to the solid support.
- Each hydrogel location is preferably about 200 micrometers in diameter, more preferably about 100 micrometers in diameter, and most preferably about 50 micrometers in diameter. Diameter is defined as the dimension parallel to the support.
- Reactive prepolymers are water-soluble copolymers that incorporate [2+2] photoreactive sites that are available for [2+2] cycloaddition type crosslinking.
- Water-solubility is measured by determining the clarity of an aqueous solution containing a specific weight percent of the reactive prepolymer. Preferable reactive prepolymer solutions are clear and contain from about 0.5% to about 22% reactive prepolymer, on a weight basis. The clarity of the reactive prepolymer when coated on the solid support is also a measure of solubility, since if precipitation occurs and water-solubility is lost, an opaque or non-uniform film results.
- Preferable water-soluble reactive prepolymers form a clear solution when an aqueous solution contains about 22% by weight, or less, of the reactive prepolymer.
- the aqueous solution to which the reactive prepolymer is added is defined as including at least 80% water by weight.
- Reactive prepolymers preferably have a weight average molecular weight of from about 1,000 to about 300,000 g/mole, more preferably about 5,000 to about 100,000 g/mole, and most preferably about 5,000 to about 50,000 g/mole.
- reactive prepolymers also can be modified from the structures described with other molecules that do not interfere with copolymerization or [2+2] cyclization.
- the reactive prepolymer's weight average molecular weight is less than about 1,000 g/mole it can become too brittle to properly coat the solid support.
- the weight average molecular weight exceeds about 300,000 g/mole, the reactive prepolymer can become too thick to coat the solid support.
- the reactive prepolymer's viscosity is preferably from about 25 centiPoise to about 500,000 centiPoise, more preferably from about 50 centiPoise to about 500,000 centipoise, and most preferably about 200 centiPoise, as measured in deionized water at about 270° C.
- the reactive prepolymer preferably includes between 1 and about 50 first monomers to each bifunctional monomer or second monomer condensed with a [2+2] photocyclizable compound. More preferably, the reactive prepolymer includes between about 10 and about 20 first monomers to each bifunctional monomer or second monomer condensed with a [2+2] photocyclizable compound. Most preferably, the reactive prepolymer includes about 15 first monomers to each bifunctional monomer or second monomer condensed with a [2+2] photocyclizable compound. By varying the amount of first monomer to the bifunctional or second monomer, the number of sites available for [2+2] cyclization may be optimized.
- a preferred reactive prepolymer has the structure:
- x is an integer from 1 to 50
- y is an integer from 1 to 50
- R is a moiety that comprises a 2+2 photoreactive site.
- Hydrogels are formed from reactive prepolymers that have had at least a portion of their [2+2] photoreactive sites photochemically crosslinked. While hydrogels are hydrophilic and tend to entrap water, they are not appreciably soluble in water. Preferably, reactive prepolymers that incorporate water-soluble monomers and monomers incorporating [2+2] photoreactive sites are crosslinked to form hydrogels. Generally, homologous hydrogels can be formed from DMI or vinyl cinnamate and heterologous hydrogels can be formed from DMI and vinyl cinnamate, DMI and an acrylate, or vinyl cinnamate and an acrylate. While these molecular pairings are preferred, any alternative compounds that provide the required functionality for polymerization and [2+2] cyclization may be used.
- hydrogels may also be formed by adding an additional crosslinking agent to the reactive prepolymer before UV irradiation.
- additional crosslinking agent increases the amount of crosslinking between the reactive prepolymers.
- Preferable additional crosslinking agents include pentaerythritol tetraacrylate.
- crosslinking agents can be [2+2] cyclized with acrylate based reactive prepolymers to form hydrogels.
- acrylate based reactive prepolymers will not cyclize with themselves, they can be cyclized into hydrogels through the addition of an additional crosslinking agent.
- hydrogels have a ratio of cyclized or crosslinked monomers to first monomers of between about one cyclized [2+2] photocyclizable monomer or compound to about every one first monomer and about one cyclized [2+2] photocyclizable monomer or compound to about every 50 first monomers. More preferably, hydrogels have a ratio of cyclized or crosslinked monomers to first monomers of between about one cyclized [2+2] photocyclizable monomer or compound to about every one first monomer and about one cyclized [2+2] photocyclizable monomer or compound to about every 30 first monomers. Most preferably, hydrogels have a ratio of about one cyclized or crosslinked [2+2] photocyclizable monomer or compound to about every 15 first monomers.
- the remaining uncrosslinked [2+2] photocyclizable monomers or compounds are available for cyclization with probes, solid supports, or other molecules.
- the approximate percent of crosslinked [2+2] photocyclizable monomers or compounds may be determined by FTIR.
- the “solid support” is any surface, including glass, silicon, modified silicon, ceramic, plastic, or polymer, such as (poly)tetrafluoroethylene, or (poly)vinylidenedifluoride, upon which the reactive prepolymer may be placed and attached.
- Preferable methods of spreading the reactive prepolymer on the solid support include, but are not limited to, roller coating, curtain coating, extrusion coating, offset printing, and spin coating. Most preferably, attachment is by a [2+2] cycloaddition of the reactive prepolymer to the solid support.
- a preferred solid support is glass.
- the solid support can be any shape or size, and can exist as a separate entity or as an integral part of any apparatus (e.g., bead, curvette, plate, or vessel).
- the solid support may inherently provide an attachment surface for the reactive prepolymer, or the solid support may be modified to provide adherence of polyacrylamide to the solid support. If the solid support is glass, it is preferably modified with with ⁇ -methacryl-oxypropyl-trimethoxysilane (“Bind Silane,” Pharmacia).
- covalent linkage of the polyacrylamide hydrogel to the solid support is performed as described in European Patent Application 0 226 470 or through [2+2] cyclization.
- the solid support may optionally contain electronic circuitry useful in the detection of bit molecules, or microfluidics used in the transport of micromolecules.
- Solvents are analytical or HPLC grade.
- General reagents can be purchased from a variety of commercial suppliers (e.g., Fluka, Aldrich, and Sigma Chemical Co.).
- Glass slides can be obtained from commercial suppliers (e.g., Corning Glass Works).
- the 20:1 dimethyl maleimide (DMI) based PRP (as depicted in FIG. 1) is a copolymer of acrylamide and bifunctional N-(6-acroloylhexyl)-2,3-dimethyl-maleimide co-monomers.
- the PRP is polyacrylamide co-N-(6-acryloylhexyl)-2,3-dimethyl-maleimide.
- the solution was deoxygenated with argon gas for 15 minutes, and then heated to 65° C. and stirred for 4 hours. After cooling to room temperature, the salts were removed from the solution by filtration over a column filled with ion exchange resin (Dowex Monosphere 450).
- the PRP was obtained by adding 0.5 gram anthroquinone 2-sulfonic acid sodium salt as a photosensitiser to 49.5 gram of the above solution recovered from the column.
- the solid content of this solution was 19.9% by weight.
- the molecular weight of the PRP was approximately 138,000 on a weight average basis and approximately 3,000 on a number average basis.
- UV crosslinking of a 5 ⁇ m coating of the DMI based PRP followed by imaging and developing operations resulted in formation of a crosslinked polyacrylamide hydrogel array.
- [0085] 15 1 glycidyl acrylate based PRP was formed by using acrylic acid as a second monomer and glycidyl acrylate as a [2+2] photocyclizable compound (as depicted in FIG. 3) or by using glycidyl acrylate as a second monomer and acrylic acid as a [2+2] photocyclizable compound.
- the polymer backbone was initially a copolymer of acrylamide and glycidyl methacrylate.
- the first copolymer formed was polyacrylamide co-glycidyl methacrylate. This first copolymer was further modified with acrylic acid to produce the PRP.
- a 20% by weight solids aqueous solution (range of from about 2% to about 40% solids) of 20:1 DMI PRP and 1% by weight anthroquinone 2-sulfonic acid sodium salt was coated on a solid support to a wet thickness of about 25 ⁇ m (range of from about 2 nanometers to about 5 ⁇ m). The coating was then exposed with UV radiation (less than about 1,000 milliJoules/cm 2 ) through a photomask containing a grid array pattern of pads (pad size of from about 1 ⁇ m to about 500 ⁇ m) to cyclize the exposed PRP into a water insoluble, crosslinked, hydrogel (FIG. 1).
- UV radiation less than about 1,000 milliJoules/cm 2
- a photomask containing a grid array pattern of pads pad size of from about 1 ⁇ m to about 500 ⁇ m
- the PRP was simultaneously crosslinked to a glass solid support modified with [2+2] photoreactive sites.
- the unexposed, and therefore still water-soluble PRP, was then selectively removed by an aqueous developer solution, leaving an array pattern of the crosslinked, porous, hydrogel.
- the solid support was then diced into individual biochips, each containing from about 500 to about 100,000 pads.
- a 20% by weight solids aqueous solution (range of from 2% to about 40% solids) of 15:1 Glycidyl Acrylate PRP containing 1% by weight pentaerythritol tetraacrylate (range of from about 0.05% to 1.5%) and 0.05% by weight anthroquinone 2-sulfonic acid sodium salt was coated on a solid support to a wet thickness of 25 ⁇ m (range of from about 1 ⁇ m to about 50 ⁇ m). The coating was then exposed with UV radiation through a photomask containing a grid array pattern of pads (pad size of from about 1 ⁇ m to about 500 ⁇ m) to cyclize the exposed PRP into a water insoluble, crosslinked hydrogel.
- the unexposed, and therefore still water-soluble PRP was then removed by an aqueous developer solution which left an array pattern of the crosslinked, porous, hydrogel.
- the solid support was diced into individual biochips, each containing from about 500 to about 100,000 hydrogel pads.
- a 20% by weight solids aqueous solution (range of from about 0.5% to about 40% solids) of 20:1 DMI PRP and 1% by weight anthroquinone 2-sulfonic acid sodium salt was coated on a solid support to a wet thickness of about 25 ⁇ m (range of from about 2 nanometers to about 5 ⁇ m).
- the coating was then exposed with UV radiation (less than about 1,000 milliJoules/cm 2 ) to cyclize the exposed PRP into a water insoluble, crosslinked, hydrogel (FIG. 1).
- the PRP was simultaneously crosslinked to a glass solid support modified with [2+2] photoreactive sites.
- the excess, and therefore still water-soluble, PRP was then removed by an aqueous developer solution, leaving a continuous film of the crosslinked, porous, hydrogel.
- a 5% by weight solids aqueous solution (range of from about 2% to about 25% solids) of an acryloyl based polyacrylamide reactive prepolymer containing 1% by weight pentaerythritol tetraacrylate and 1% by weight of an anthroquinone 2-sulfonic acid sodium salt photosensitiser was coated in a grid array pattern (pad size from about 50 ⁇ m to about 500 ⁇ m) by offset printing on a solid support to a wet thickness of 25 ⁇ m (range of from about 1 ⁇ m to about 50 ⁇ m).
- the patterned coating was then exposed with UV radiation to cyclize the exposed PRP into a water insoluble hydrogel, leaving an array pattern of crosslinked, hydrogel material.
- the solid support was diced into individual biochips, each containing from about 500 to about 100,000 hydrogel pads.
- a solution of acrylamide and acrylic acid (from about 3% to about 50% acrylic acid) is thermally polymerized between 40 and 50° C.
- a copolymer of acrylamide and acrylic acid is formed as depicted in FIG. 2. This resultant copolymer is condensed with acryloyl chloride to obtain an acrylate based polyacrylamide reactive prepolymer (PRP) ready for crosslinking.
- PRP polyacrylamide reactive prepolymer
Abstract
Description
- This application is a continuation-in-part of U.S. Nonprovisional Application No. 09/344,217, filed Jun. 25, 1999, entitled “Polyacrylamide Hydrogels and Hydrogel Arrays Made from Polyacrylamide Reactive Prepolymers,” which claimed the benefit of U.S. Provisional Application No. 60/109,821, filed Nov. 25, 1998 entitled “Polyacrylamide Hydrogels and Hydrogel Arrays Made from Polyacrylamide Reactive Prepolymers.”
- Acrylamide (CH2═CHC(O)NH2; C.A.S. 79-06-1; also known as acrylamide monomer, acrylic amide, propenamide, and 2-propenamide) is an odorless, free-flowing white crystalline substance that may be polymerized to form polyacrylamides. The resulting high molecular weight polymers have a variety of uses and further can be modified to optimize nonionic, anionic, or cationic properties for specified uses.
- Polyacrylamide hydrogels are used as molecular sieves for the separation of nucleic acids, proteins, peptides, oligonucleotides, polynucleotides, and other biological materials. They are also used as binding layers for biological materials. When used as binding layers, the gels currently are produced as thin sheets or slabs, typically by depositing a solution of acrylamide monomer, a crosslinker such methylene bisacrylamide, and an initiator such as N,N,N′,N′-tetramethylethylendiamine (TEMED) between two glass surfaces (e.g., glass plates or microscope slides) using a spacer to obtain the desired thickness of polyacrylamide.
- Generally, the acrylamide polymerization solution is a 4-5% solution (acrylamide/bisacrylamide 19/1) in water/glycerol, with a nominal amount of initiator. The acrylamide is chain-polymerized and crosslinked by radical initiation from ultraviolet (UV) radiation (e.g., 254 nm for about 15 minutes) or heat (e.g., about 400° C.). Following polymerization and crosslinking, the top glass slide is removed from the surface to uncover the gel. Changing the amount of crosslinker and the % solids in the monomer solution controls the pore size of the gel. Changing the polymerization temperature also can control the pore size.
- The current approach of making polyacrylamide hydrogels starting from acrylamide monomer has several disadvantages, some of which are described below:
- 1. The coating process is difficult and expensive to automate because the film thickness is controlled with a spacer and top glass plate. The removal of the top glass plate must be done manually. Due to difficulties automating the process (e.g., viscosity too low for commercial coating methods), the coating of the monomer solution currently is done manually.
- 2. The reaction time of the acrylamide is excessively long (e.g., typically from about 15 to about 90 minutes at a short wavelength of about 254 nm), making the UV polymerization and crosslinking step incompatible with standard imaging equipment such as mask aligners and photoprinters.
- 3. The acrylamide monomer is a neurotoxin and a carcinogen which makes coating, handling, and waste disposal of the material hazardous and expensive.
- Added to these disadvantages are the further problems that crystallization of monomer frequently occurs on commonly used equipment and laboratory surfaces, and exothermic polymerization can occur in coating reservoirs, necessitating the use of stabilizers or inhibitors. The present invention overcomes at least one of these disadvantages.
- Polyacrylamide hydrogels that incorporate [2+2] photoreactive sites are disclosed. The hydrogels are especially useful for microarray formation and are made from prepolymers, including polyacrylamide reactive prepolymers. The photoreactive sites allow use of [2+2] cycloaddition reactions to not only crosslink the polyacrylamide reactive prepolymers forming the hydrogel, but also for later attachment of any other molecules incorporating additional photoreactive sites. The disclosed hydrogels provide a more uniform pore size, likely resulting from an improved control of crosslinking, making them preferable for use with DNA based probes. Additionally, because higher viscosity prepolymers, as opposed to low viscosity monomer solutions, are used to form the arrays, manufacturing is simplified.
- The scope of the present invention is defined solely by the appended claims, and is not affected to any degree by the statements within this summary.
- FIG. 1 depicts a DMI based polyacrylamide reactive prepolymer formed by a “one-step” process. The polyacrylamide reactive prepolymer (PRP) was formed by thermally polymerizing monomers of acrylamide and N-(6-acryloylhexyl)-2,3-dimethylmaleimide. Because N-(6-acryloylhexyl)-2,3-dimethylmaleimide is “bifunctional,” (having both a polymerizable functionality and a [2+2] photoreactive site in a single molecule) it forms a PRP directly upon copolymerization with acrylamide. Upon irradiation with ultraviolet light, the PRP is crosslinked to form a hydrogel by cycloaddition at the [2+2] photoreactive sites. Substituents x and y can be varied between 1 and 50. The wavy line (~~~~~) between oxygen and nitrogen represents the hexyl spacer group. The dashed bonds (———) indicate attachment points for additional monomers.
- FIG. 2 depicts a “two-step” reaction scheme for reactive prepolymer formation. First, a copolymer of acrylamide and acrylic acid is formed. Second, the copolymer is treated with a [2+2] photoreactive compound, such as acryloyl chloride. The acrylic acid monomer then condenses with the acryloyl chloride to give a PRP with an acrylate provided [2+2] photoreactive site. Substituents x and y can be varied between 1 and 50. The dashed bonds indicate attachment points for additional monomers.
- FIG. 3 depicts a Glycidyl Methacrylate Based PRP resulting from a two-step process in which a copolymer of acrylamide and acrylic acid is reacted with glycidyl methacrylate. An acrylate provided [2+2] photoreactive site results. Because [2+2] photoreactive sites provided by acrylate groups will not photocyclize with themselves, but will undergo undesirable chain-type polymerization if irradiated with UV light, a mixed hydrogel is formed by ultraviolet exposure in the presence of a DMI based PRP. Alternatively, an additional crosslinking agent can be used to form a hydrogel from the acrylate based PRP. Substituents x and y can be varied between 1 and 50. The dashed bonds indicate attachment points for additional monomers.
- Overview
- Hydrogels suitable for forming microarrays and continuous films to which probes may be attached by [2+2] photocycloaddition chemistry are described. The arrays or films are formed by first synthesizing a reactive prepolymer that incorporates [2+2] photocyclizable sites. A thin layer of prepolymer solution is then placed on a solid support and exposed to ultraviolet light. If microarrays are desired, the hydrogel layer is selectively exposed to ultraviolet light. During exposure, a portion of the [2+2] photocyclizable sites exposed to the light undergoes cyclization to crosslink the reactive prepolymer, thus forming a hydrogel. The uncyclized reactive prepolymer is then washed away with an aqueous solution. Unlike the reactive prepolymer, the crosslinked hydrogel is not water-soluble. A continuous hydrogel film or microarray of hydrogel sites attached to the solid support results.
- Probes or other molecules containing [2+2] photoreactive sites may undergo cycloaddition with the hydrogel through further UV exposure. Sufficient [2+2] photoreactive sites are incorporated into the reactive prepolymer to crosslink the polymer to form the hydrogel and to remain available for later probe and other molecule attachment.
- For arrays, the hydrogel pattern results from selective irradiation with ultraviolet light. Selective irradiation may be accomplished in multiple ways known to those of skill in the art. Preferable methods include (1) using an opaque mask to shield portions of the reactive prepolymer from ultraviolet exposure and (2) using a laser beam to only irradiate selected positions on the reactive prepolymer. Either method results in only selected portions of the reactive polymer being crosslinked. The uncrosslinked reactive polymer can then be removed to leave the array grid on the support.
- Reactive Prepolymer
- While a variety of compounds or molecules may be used to form the reactive prepolymer, two basic procedures are preferred. In the first, a bifunctional molecule with a polymerizable end and a [2+2] photocyclizable end is copolymerized with a hydrophilic first monomer. In the second, a second monomer that may be attached to a compound having a [2+2] photoreactive site is copolymerized with the hydrophilic first monomer. This copolymer is then reacted with a compound having a [2+2] photoreactive site to produce the desired reactive prepolymer. Either method results in a reactive prepolymer that may be crosslinked into a hydrogel by [2+2] photocycloaddition.
- Monomers
- [0019] Monomers are the individual molecular units that are repeated to form polymers. Multiple monomers covalently attached form the backbone of a polymer. Polymers that are made from at least two different monomer units are referred to as copolymers. Polymerizing or copolymerizing describes the process by which multiple monomers are covalently linked to form polymers or copolymers, respectively. A discussion of polymers and monomers from which they are made may be found in Stevens,Polymer Chemistry: An Introduction, 3rd ed., Oxford University Press, 1999. The preferred embodiments rely on three general classes of monomers to form reactive prepolymers.
- The monomers used in the preferred embodiments may be covalently attached by chain-type polymerization chemistry to form the backbone of the reactive prepolymer. Thus, these monomers are “polymerizable.”
- Chain-type Polymerization
- Chain-type polymerization is a polymerization reaction that is radical initiated. An energetic radical is formed in the presence of the monomers, which then join to form a polymer. Many methods of radical initiation are known, but most rely on thermal or light energy to generate the reactive radicals. In one embodiment, thermal radical initiation is most preferred to form a polymer backbone incorporating acrylamide first monomers.
-
- In order to undergo chain-type polymerization, a monomer must have “polymerizable functionality,” as provided by the olefins in the butylenes depicted above. During this butylene polymerization, for example, the unsaturated monomers covalently bond to form a saturated polybutylene polymer. The monomers are covalently attached through their polymerizable groups.
- First Monomers
- The first type of monomer, or “first monomer,” is preferably water-soluble and polymerizable. First monomers may be copolymerized by chain-type methods with other polymerizable monomers and impart hydrophilicity to the resultant copolymer. After polymerization, the first monomers are covalently bonded to themselves or other polymerizable monomers. They are also resistant to [2+2] cyclization reactions as described below. By cyclization resistant, it is meant that when heated or exposed to ultraviolet light, first monomers will preferentially undergo chain-type polymerization in relation to [2+2] cyclization.
- Monomers that undergo chain-type radical polymerization, resist [2+2] photocyclization, and solubilize in water are preferred first monomers. Examples of preferred first monomers include acrylamide, hydroxyethyl acrylate, vinyl pyridine, acrylic acid, methacrylic acid, and vinyl pyrrolidone, or mixtures thereof. Most preferred is acrylamide.
- Second Monomer
- The second type of monomer, or “second monomer,” may be copolymerized by chain-type methods with other polymerizable monomers and includes a heteroatom (e.g. oxygen, nitrogen, sulfur, phosphorous). After copolymerization, the heteroatom may be used to covalently attach the second monomer to a [2+2] photocyclizable compound by a condensation reaction.
- A condensation reaction occurs when two molecules are covalently joined through a non-radical pathway. The condensation of acrylic acid with glycidyl methacrylate is shown below. In this reaction the oxygen heteroatom of acrylic acid opens the epoxide ring of glycidyl acrylate to form a covalent bond.
- Preferred second monomers can be any monomer that is polymerizable and has a heteroatom suitable for bonding with a compound having a [2+2] photoreactive site, as described below. More preferred second monomers include acrylic acid, glycidyl methacrylate, and methacrylic acid, or mixtures thereof. Acrylic acid is most preferred.
- Preferable [2+2] photocyclizable compounds include any compound incorporating a [2+2] photoreactive site that can undergo a condensation reaction with a second monomer. More preferred [2+2] photocyclizable compounds include glycidyl methacrylate, acrylic acid, hydroxyethyl acrylate, hydroxypropyl acrylate, and acryloyl halides, or mixtures thereof.
- Bifunctional Monomers
- The third type of monomers used to form reactive prepolymers includes both polymerizable functionality and [2+2] photoreactive sites in a single monomer. By tuning the electron density and steric parameters of a monomer to favor polymerization (greater electron density, less sterics) at one end and to favor [2+2] cycloaddition (less electron density, greater sterics) at the other, bifunctional monomers may be formed. When copolymerized with first monomers, bifunctional monomers form reactive prepolymers without requiring further incorporation of [2+2] photocyclizable compounds. Preferably, bifunctional monomers are thermally copolymerized with a first monomer and then exposed to ultraviolet light to crosslink a portion of the [2+2] photoreactive sites to form a hydrogel.
-
- [2+2] Photocyclizable Monomer
- [0032] [2+2] photoreactive sites can undergo [2+2] photocycloaddition and are therefore [2+2] photocyclizable. [2+2] photocyclizable monomers are preferably any monomer unit that includes a [2+2] photoreactive site and a polymerizable site. Therefore, [2+2] photocyclizable monomers can be either bifunctional, like DMI, or made through condensation of a polymerizable compound with a [2+2] photocyclizable compound.
- A monomer or compound incorporating a [2+2] photoreactive site can undergo [2+2] cycloaddition with other monomers or compounds that possess a [2+2] photoreactive site. If a monomer or compound incorporating a [2+2] photoreactive site is irradiated with ultraviolet light, the [2+2] reactive portion of the molecule will preferentially undergo cycloaddition or “cyclize” with other [2+2] photoreactive sites, instead of undergoing chain-type polymerization. Preferably, polymerizable sites have a greater electron density and are less sterically hindered than [2+2] photoreactive sites.
- While second monomers and [2+2] photocyclizable compounds serve different chemical functions in the present embodiments, some molecules can provide either functionality depending on reaction order. For example, if acrylamide is copolymerized with acrylic acid and then condensed with glycidyl methacrylate, acrylic acid provides second monomer functionality and glycidyl methacrylate provides [2+2] photocyclizable compound functionality. Alternatively, if acrylamide is copolymerized with glycidyl methacrylate and then condensed with acrylic acid, glycidyl methacrylate provides second monomer functionality and acrylic acid provides [2+2] photocyclizable compound functionality. In either reaction sequence, a PRP is formed with an acrylate based [2+2] photoreactive site. This reversibility holds true for the reaction of acrylic acid with glycidyl methacrylate, hydroxyethyl acrylate, or hydroxypropyl acrylate. Hence, reaction order can determine whether a compound serves as a second monomer or a [2+2] photoreactive compound during two-step reactive prepolymer synthesis.
- [2+21] Cyclization
- In the disclosed embodiments, [2+2] cyclization or cycloaddition is a light-induced reaction between two photoreactive sites, at least one of which is electronically excited. Advantageously, [2+2] cycloaddition reactions can proceed with high efficiency. While it is chemical convention to write cycloaddition centers in brackets, such as “[2+2]” or “[4+2],” the brackets were omitted from the claims to prevent confusion with the patent convention of deleting bracketed material. Hence, in the claims “[2+2]” is written as “2+2.”
- Most preferably, cyclization is of the [2+2] variety, wherein two carbon-carbon or a carbon-carbon and a carbon-heteroatom single bond are formed in a single step. The [2+2] cycloaddition involves addition of a 2π-component of a double bond to the 2π-component of a second double bond, as shown below.
- Alternatively, the reaction may proceed by way of a 2π-component of triple bonds. Under the rules of orbital symmetry, such [2+2] cycloadditions are thermally forbidden, but photochemically allowed. Such reactions typically proceed with a high degree of stereospecificity and regiospecificity.
- Photochemical [2+2] cycloaddition of monomers on opposing copolymer chains results in crosslinking of the copolymer backbones. In addition to cyclizing with other photocyclizable monomers, [2+2] photocyclizable monomers can cyclize with other molecules, such as DNA probes, which incorporate [2+2] photoreactive sites. In this manner, other molecules may be attached to the preferred hydrogels. The additional [2+2] cyclizable molecules may be cyclized with the monomers during or after the cyclization reaction that crosslinks the monomers to form the hydrogel. The cyclization between monomers results in covalent crosslinking to form hydrogels, while cyclization between monomers and other molecules results in covalent attachment of the other molecules to the hydrogel. In a likewise fashion, the reactive prepolymer may be cyclized to a solid support, such as glass or plastic, which incorporates [2+2] photoreactive sites.
- Preferred [2+2] cycloadditions include those between two carbon-carbon double bonds to form cyclobutanes and those between alkenes and carbonyl groups to form oxetanes. Cycloadditions between two alkenes to form cyclobutanes can be carried out by photo-sensitization with mercury or directly with short wavelength light, as described in Yamazaki et al.,J. Am. Chem. Soc., 91, 520 (1969). The reaction works particularly well with electron-deficient double bonds because electron-poor olefins are less likely to undergo undesirable side reactions. Cycloadditions between carbon-carbon and carbon-oxygen double bonds, such as α,β-unsaturated ketones, form oxetanes (Weeden, In Synthetic Organic Photochemistry,
Chapter 2, W. M. Hoorspool (ed.) Plenum, New York, 1984) and enone addition to alkynes (Cargill et al., J. Org. Chem., 36, 1423 (1971)). - Photoreactive Sites
- Photoreactive sites are defined as chemical bonds capable of undergoing [2+2] cycloaddition (cyclization) to form a ring structure when exposed to light of an appropriate wavelength. Photoreactive sites can yield homologous linking, where a monomer or other molecule photoreactive site cyclizes with a monomer or other molecule photoreactive site having the same chemical structure, or for heterologous linking, where a monomer or other molecule photoreactive site cyclizes with a monomer or other molecule photoreactive site having a different chemical structure.
- In the current embodiments, DMI and vinyl cinnamate [2+2] photoreactive sites can cyclize with themselves, each other, or acrylate provided [2+2] photoreactive sites. Unlike the photoreactive sites of DMI and vinyl cinnamate, however, acrylate provided [2+2] photoreactive sites do not undergo [2+2] photocycloaddition with themselves. Preferred homologous linking occurs between dimethyl maleimide (DMI) photoreactive sites, while preferred heterologous linking occurs between acrylate and DMI photoreactive sites. A detailed discussion of photoreactive sites may be found in Guillet,Polymer Photophysics and Photochemistry, Ch. 12 (Cambridge University Press: Cambridge, London). Generally, double bonds that are not part of a highly conjugated system (e.g. benzene will not work) are preferred. Sterically-hindered, electron deficient double bonds, such as found in maleimide, are most preferred.
- Additionally, molecules having a structure similar to dimethyl maleimide may be used as photoreactive sites, including maleimide/N-hydroxysuccinimide (NHS) ester derivatives. Such preferred maleimide/NHS esters include 3-maleimidoproprionic acid hydroxysuccinimide ester; 3-maleimidobenzoic acid N-hydroxy succinimide; N-succinimidyl 4-malimidobutyrate; N-succinimidyl 6-maleimidocaproate; N-succinimidyl 8-maleimidocaprylate; N-succinimidyl 11-maleimidoundecaoate. These esters can be obtained from a variety of commercial vendors, such as ALDRICH (Milwaukee, Wis).
- Ultraviolet Irradiation
- Crosslinking of the [2+2] photoreactive sites of the photocyclizable monomers in the reactive prepolymer is most preferably done with ultraviolet irradiation. Optionally, a photosensitiser may be added to the reactive prepolymer to increase the efficiency of the cycloaddition reaction. Preferred photosensitisers include water-soluble quinones and xanthones, including anthroquinone, thioxanthone, sulfonic acid quinone, benzoin ethers, acetophenones, benzoyl oximes, acylphosphines, benzophenones, and TEMED (N,N,N′,N′-tetramethylethylendiamine). Anthroquinone-2-sulfonic acid is most preferred and is available from ALDRICH, Milwaukee, Wis.
- While irradiation by light in the ultraviolet spectrum between 250 and 450 nanometers is preferred, longer wavelength ultraviolet radiation is more preferred. Light of about 365 nanometers in wavelength is most preferred. By using longer wavelength ultraviolet light, possible damage of other molecules, such as DNA probes that degrade at 256 nanometers, is avoided. Irradiation is preferably carried out between 22 and 300° C.
- The reactive prepolymer is irradiated with ultraviolet light for preferably between 10 and 100 seconds, most preferably for about 30 seconds. Longer irradiation times result in thicker hydrogels, while shorter irradiation times yield thinner hydrogels. Useful hydrogels are preferably from about 2 nanometers to about 5 micrometers in thickness, more preferably from about 2 nanometers to about 100 nanometers in thickness, and most preferably from about 2 nanometers to about 50 nanometers in thickness. Thickness is defined as the dimension perpendicular to the support.
- While irradiation may be carried out with any device capable of producing light at the preferred wavelengths, a photolithography tool, such as a metal halide lamp equipped Calibre ORC, available from Mentor Graphics (Wilsonville, Oreg.), is most preferred.
- Microarray Formation
- To form a microarray, it is preferable to selectively crosslink only a portion of the reactive prepolymer present on the solid support, thus forming a pattern or grid of separate hydrogel locations. One method of accomplishing this goal is after application of the reactive prepolymer to the support, the reactive prepolymer is covered with a mask having only a portion of its surface transparent to the irradiation light. When the mask is then irradiated, only the portion exposed to the light crosslinks to form a hydrogel. The uncrosslinked reactive polymer is then removed, preferably with aqueous solutions. In this fashion, the pattern of the mask is transferred to the hydrogel microarray. See Sze,VLSI Technology, McGraw-Hill (1983).
- Patterned hydrogel microarrays can also be formed on the support by using an ultraviolet laser to only irradiate the portions of the reactive prepolymer where a hydrogel is desired. See U.S. Pat. No. 4,719,615. After this targeted irradiation, the excess reactive polymer is removed, leaving a microarray of individual hydrogel locations. For either method, the hydrogel locations may preferably be arranged in rows and columns.
- Preferably each location of hydrogel extends from about 2 nanometers to about 5 microns, more preferably from about 2 nanometers to about 100 nanometers, and most preferably from about 2 nanometers to about 50 nanometers in the direction perpendicular to the solid support. Each hydrogel location is preferably about 200 micrometers in diameter, more preferably about 100 micrometers in diameter, and most preferably about 50 micrometers in diameter. Diameter is defined as the dimension parallel to the support.
- Spacers
- Spacers are preferably groups that neither polymerize nor undergo [2+2] cyclization during reactive prepolymer and hydrogel formation and separate the polymerizable and [2+2] photoreactive sites of bifunctional monomers. Spacers may also be used to physically separate second monomers from [2+2] photoreactive sites before condensation of the second monomer with the [2+2] photocyclizable compound. More preferred spacers are —CH2)n— (methylene) or —(OCH2CH2)n— (ethylene oxide), most preferably where n=1-10. A—(CH2)6— spacer is present in N-(6-acryloylhexyl)-2,3-dimethylmaleimide, as shown above.
- Reactive Prepolymers
- Reactive prepolymers are water-soluble copolymers that incorporate [2+2] photoreactive sites that are available for [2+2] cycloaddition type crosslinking. Water-solubility is measured by determining the clarity of an aqueous solution containing a specific weight percent of the reactive prepolymer. Preferable reactive prepolymer solutions are clear and contain from about 0.5% to about 22% reactive prepolymer, on a weight basis. The clarity of the reactive prepolymer when coated on the solid support is also a measure of solubility, since if precipitation occurs and water-solubility is lost, an opaque or non-uniform film results. Preferable water-soluble reactive prepolymers form a clear solution when an aqueous solution contains about 22% by weight, or less, of the reactive prepolymer. The aqueous solution to which the reactive prepolymer is added is defined as including at least 80% water by weight.
- Reactive prepolymers preferably have a weight average molecular weight of from about 1,000 to about 300,000 g/mole, more preferably about 5,000 to about 100,000 g/mole, and most preferably about 5,000 to about 50,000 g/mole. However, reactive prepolymers also can be modified from the structures described with other molecules that do not interfere with copolymerization or [2+2] cyclization.
- Generally, if the reactive prepolymer's weight average molecular weight is less than about 1,000 g/mole it can become too brittle to properly coat the solid support. Alternatively, if the weight average molecular weight exceeds about 300,000 g/mole, the reactive prepolymer can become too thick to coat the solid support. Thus, the reactive prepolymer's viscosity is preferably from about 25 centiPoise to about 500,000 centiPoise, more preferably from about 50 centiPoise to about 500,000 centipoise, and most preferably about 200 centiPoise, as measured in deionized water at about 270° C.
- The reactive prepolymer preferably includes between 1 and about 50 first monomers to each bifunctional monomer or second monomer condensed with a [2+2] photocyclizable compound. More preferably, the reactive prepolymer includes between about 10 and about 20 first monomers to each bifunctional monomer or second monomer condensed with a [2+2] photocyclizable compound. Most preferably, the reactive prepolymer includes about 15 first monomers to each bifunctional monomer or second monomer condensed with a [2+2] photocyclizable compound. By varying the amount of first monomer to the bifunctional or second monomer, the number of sites available for [2+2] cyclization may be optimized.
-
- where x is an integer from 1 to 50, y is an integer from 1 to 50, and R is a moiety that comprises a 2+2 photoreactive site.
- Hydrogels
- Hydrogels are formed from reactive prepolymers that have had at least a portion of their [2+2] photoreactive sites photochemically crosslinked. While hydrogels are hydrophilic and tend to entrap water, they are not appreciably soluble in water. Preferably, reactive prepolymers that incorporate water-soluble monomers and monomers incorporating [2+2] photoreactive sites are crosslinked to form hydrogels. Generally, homologous hydrogels can be formed from DMI or vinyl cinnamate and heterologous hydrogels can be formed from DMI and vinyl cinnamate, DMI and an acrylate, or vinyl cinnamate and an acrylate. While these molecular pairings are preferred, any alternative compounds that provide the required functionality for polymerization and [2+2] cyclization may be used.
- While not necessary, hydrogels may also be formed by adding an additional crosslinking agent to the reactive prepolymer before UV irradiation. The inclusion of an additional crosslinking agent increases the amount of crosslinking between the reactive prepolymers. Preferable additional crosslinking agents include pentaerythritol tetraacrylate. Additionally, crosslinking agents can be [2+2] cyclized with acrylate based reactive prepolymers to form hydrogels. Thus, while acrylate based reactive prepolymers will not cyclize with themselves, they can be cyclized into hydrogels through the addition of an additional crosslinking agent.
- Preferably, hydrogels have a ratio of cyclized or crosslinked monomers to first monomers of between about one cyclized [2+2] photocyclizable monomer or compound to about every one first monomer and about one cyclized [2+2] photocyclizable monomer or compound to about every 50 first monomers. More preferably, hydrogels have a ratio of cyclized or crosslinked monomers to first monomers of between about one cyclized [2+2] photocyclizable monomer or compound to about every one first monomer and about one cyclized [2+2] photocyclizable monomer or compound to about every 30 first monomers. Most preferably, hydrogels have a ratio of about one cyclized or crosslinked [2+2] photocyclizable monomer or compound to about every 15 first monomers.
- Of the total [2+2] photocyclizable monomers or compounds present in the reactive prepolymer, preferably between 10% and 80% are crosslinked to form the hydrogel, more preferably between 20% and 65% are crosslinked to form the hydrogel, and most preferably between 30% and 50% are crosslinked to form the hydrogel. The remaining uncrosslinked [2+2] photocyclizable monomers or compounds are available for cyclization with probes, solid supports, or other molecules. The approximate percent of crosslinked [2+2] photocyclizable monomers or compounds may be determined by FTIR.
- Solid Supports
- The “solid support” is any surface, including glass, silicon, modified silicon, ceramic, plastic, or polymer, such as (poly)tetrafluoroethylene, or (poly)vinylidenedifluoride, upon which the reactive prepolymer may be placed and attached. Preferable methods of spreading the reactive prepolymer on the solid support include, but are not limited to, roller coating, curtain coating, extrusion coating, offset printing, and spin coating. Most preferably, attachment is by a [2+2] cycloaddition of the reactive prepolymer to the solid support. A preferred solid support is glass.
- The solid support can be any shape or size, and can exist as a separate entity or as an integral part of any apparatus (e.g., bead, curvette, plate, or vessel). The solid support may inherently provide an attachment surface for the reactive prepolymer, or the solid support may be modified to provide adherence of polyacrylamide to the solid support. If the solid support is glass, it is preferably modified with with γ-methacryl-oxypropyl-trimethoxysilane (“Bind Silane,” Pharmacia).
- More preferably, covalent linkage of the polyacrylamide hydrogel to the solid support is performed as described in European Patent Application 0 226 470 or through [2+2] cyclization. The solid support may optionally contain electronic circuitry useful in the detection of bit molecules, or microfluidics used in the transport of micromolecules.
- The preceding description is not intended to limit the scope of the invention to the preferred embodiments described, but rather to enable any person skilled in the art of chemistry to make and use the invention.
- Solvents are analytical or HPLC grade. General reagents can be purchased from a variety of commercial suppliers (e.g., Fluka, Aldrich, and Sigma Chemical Co.). Glass slides can be obtained from commercial suppliers (e.g., Corning Glass Works).
- The 20:1 dimethyl maleimide (DMI) based PRP (as depicted in FIG. 1) is a copolymer of acrylamide and bifunctional N-(6-acroloylhexyl)-2,3-dimethyl-maleimide co-monomers. Thus, the PRP is polyacrylamide co-N-(6-acryloylhexyl)-2,3-dimethyl-maleimide.
- First, 17.06 gram (0.24 mol.) of acrylamide (Fluka BioChemica, electrophoresis grade), 3.35 gram (0.012 mol.) of N-(6-acroloylhexyl)-2,3-dimethyl-maleimide, 0.39 gram (0.00156 mol.) of copper(II)sulfate pentahydrate, and 0.3 gram (0.00111 mol.) of potassium peroxodisulfate were dissolved in 81.6 gram of n-propanol/water 2:1 in a 250 mL-3-neck flask equipped with a condenser, a stirrer, and a gas inlet/outlet. The solution was deoxygenated with argon gas for 15 minutes, and then heated to 65° C. and stirred for 4 hours. After cooling to room temperature, the salts were removed from the solution by filtration over a column filled with ion exchange resin (Dowex Monosphere 450).
- The PRP was obtained by adding 0.5 gram anthroquinone 2-sulfonic acid sodium salt as a photosensitiser to 49.5 gram of the above solution recovered from the column. The solid content of this solution was 19.9% by weight. The molecular weight of the PRP was approximately 138,000 on a weight average basis and approximately 3,000 on a number average basis. UV crosslinking of a 5 μm coating of the DMI based PRP followed by imaging and developing operations resulted in formation of a crosslinked polyacrylamide hydrogel array.
-
- First, 15.99 gram (0.225 mol.) of acrylamide (Fluka BioChemica, electrophoresis grade), 2.13 gram (0.015 mol.) of glycidyl methacrylate, 0.39 gram (0.00156 mol.) of copper(II)sulfate pentahydrate, and 0.3 gram (0.00111 mol.) of potassium peroxodisulfate were dissolved in 82.5 gram of n-propanole/water 2:1 in a 250 mL-3-neck flask equipped with a condenser, a stirrer, and a gas inlet/outlet. The solution was deoxygenated with argon gas for 15 minutes, and then was heated up to 65° C. and stirred at this temperature for 4 hours. After cooling to room temperature, the salts were removed from the solution by filtration over a column filled with ion exchange resin (Dowex Monosphere 450).
- Forty-five grams of the solution recovered from the column and 0.47 gram (0.0065 mol.) of acrylic acid were combined in a 100 mL flask equipped with a condenser and stirred (magnetic stirrer bar) for 20 hours at 90° C. with external heating. The PRP was obtained after adding 0.45 gram anthroquinone 2-sulfonic acid sodium salt and 0.25 gram triethanol amine to the acrylated acrylamide solution. The solid content of this solution was 23.8% by weight.
- A 20% by weight solids aqueous solution (range of from about 2% to about 40% solids) of 20:1 DMI PRP and 1% by weight anthroquinone 2-sulfonic acid sodium salt was coated on a solid support to a wet thickness of about 25 μm (range of from about 2 nanometers to about 5 μm). The coating was then exposed with UV radiation (less than about 1,000 milliJoules/cm2) through a photomask containing a grid array pattern of pads (pad size of from about 1 μm to about 500 μm) to cyclize the exposed PRP into a water insoluble, crosslinked, hydrogel (FIG. 1). Although not shown in FIG. 1, the PRP was simultaneously crosslinked to a glass solid support modified with [2+2] photoreactive sites. The unexposed, and therefore still water-soluble PRP, was then selectively removed by an aqueous developer solution, leaving an array pattern of the crosslinked, porous, hydrogel. Optionally, the solid support was then diced into individual biochips, each containing from about 500 to about 100,000 pads.
- A 20% by weight solids aqueous solution (range of from 2% to about 40% solids) of 15:1 Glycidyl Acrylate PRP containing 1% by weight pentaerythritol tetraacrylate (range of from about 0.05% to 1.5%) and 0.05% by weight anthroquinone 2-sulfonic acid sodium salt was coated on a solid support to a wet thickness of 25 μm (range of from about 1 μm to about 50 μm). The coating was then exposed with UV radiation through a photomask containing a grid array pattern of pads (pad size of from about 1 μm to about 500 μm) to cyclize the exposed PRP into a water insoluble, crosslinked hydrogel. The unexposed, and therefore still water-soluble PRP was then removed by an aqueous developer solution which left an array pattern of the crosslinked, porous, hydrogel. Optionally, the solid support was diced into individual biochips, each containing from about 500 to about 100,000 hydrogel pads.
- A 20% by weight solids aqueous solution (range of from about 0.5% to about 40% solids) of 20:1 DMI PRP and 1% by weight anthroquinone 2-sulfonic acid sodium salt was coated on a solid support to a wet thickness of about 25 μm (range of from about 2 nanometers to about 5 μm). The coating was then exposed with UV radiation (less than about 1,000 milliJoules/cm2) to cyclize the exposed PRP into a water insoluble, crosslinked, hydrogel (FIG. 1). Although not shown in FIG. 1, the PRP was simultaneously crosslinked to a glass solid support modified with [2+2] photoreactive sites. The excess, and therefore still water-soluble, PRP was then removed by an aqueous developer solution, leaving a continuous film of the crosslinked, porous, hydrogel.
- A 5% by weight solids aqueous solution (range of from about 2% to about 25% solids) of an acryloyl based polyacrylamide reactive prepolymer containing 1% by weight pentaerythritol tetraacrylate and 1% by weight of an anthroquinone 2-sulfonic acid sodium salt photosensitiser was coated in a grid array pattern (pad size from about 50μm to about 500 μm) by offset printing on a solid support to a wet thickness of 25 μm (range of from about 1 μm to about 50 μm).
- The patterned coating was then exposed with UV radiation to cyclize the exposed PRP into a water insoluble hydrogel, leaving an array pattern of crosslinked, hydrogel material. Optionally, the solid support was diced into individual biochips, each containing from about 500 to about 100,000 hydrogel pads.
- A solution of acrylamide and acrylic acid (from about 3% to about 50% acrylic acid) is thermally polymerized between 40 and 50° C. A copolymer of acrylamide and acrylic acid is formed as depicted in FIG. 2. This resultant copolymer is condensed with acryloyl chloride to obtain an acrylate based polyacrylamide reactive prepolymer (PRP) ready for crosslinking. This reaction sequence graphically depicted in FIG. 2.
- As any person skilled in the art of chemistry will recognize from the previous description, figures, and examples that modifications and changes can be made to the preferred embodiments of the invention without departing from the scope of the invention defined by the following claims.
Claims (80)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/131,426 US20020115740A1 (en) | 1998-11-25 | 2002-04-23 | Hydrogels and hydrogel arrays made from reactive prepolymers crosslinked by [2 + 2] cycloaddition |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10982198P | 1998-11-25 | 1998-11-25 | |
US09/344,217 US6391937B1 (en) | 1998-11-25 | 1999-06-25 | Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers |
US10/131,426 US20020115740A1 (en) | 1998-11-25 | 2002-04-23 | Hydrogels and hydrogel arrays made from reactive prepolymers crosslinked by [2 + 2] cycloaddition |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/344,217 Continuation-In-Part US6391937B1 (en) | 1998-11-25 | 1999-06-25 | Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020115740A1 true US20020115740A1 (en) | 2002-08-22 |
Family
ID=26807404
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/344,217 Expired - Fee Related US6391937B1 (en) | 1998-11-25 | 1999-06-25 | Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers |
US10/131,426 Abandoned US20020115740A1 (en) | 1998-11-25 | 2002-04-23 | Hydrogels and hydrogel arrays made from reactive prepolymers crosslinked by [2 + 2] cycloaddition |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/344,217 Expired - Fee Related US6391937B1 (en) | 1998-11-25 | 1999-06-25 | Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers |
Country Status (3)
Country | Link |
---|---|
US (2) | US6391937B1 (en) |
AU (1) | AU2028500A (en) |
WO (1) | WO2000031148A2 (en) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6686161B2 (en) * | 1999-06-25 | 2004-02-03 | Amersham Biosciences Ab | Methods and compositions for attachment of biomolecules to solid supports, hydrogels, and hydrogel arrays |
US20060141464A1 (en) * | 2002-11-29 | 2006-06-29 | Marcella Chiari | Method for immobilizing biologic molecules on solid surfaces |
US20070062813A1 (en) * | 2005-09-20 | 2007-03-22 | Erik Gentalen | Electrophoresis standards, methods and kits |
US20090317442A1 (en) * | 2006-07-10 | 2009-12-24 | Medipacs, Inc. | Super Elastic Epoxy Hydrogel |
WO2010005290A1 (en) * | 2008-07-11 | 2010-01-14 | Parvus Beheer B.V. | Method for the preparation of a biocompatible hydrogel |
US20100285094A1 (en) * | 2006-04-20 | 2010-11-11 | University Of Utah Research Foundation | Polymeric compositions and methods of making and using thereof |
US20110195527A1 (en) * | 2004-07-19 | 2011-08-11 | Cell Biosciences, Inc. | Methods and devices for analyte detection |
US20110198004A1 (en) * | 2005-10-20 | 2011-08-18 | Mark Banister | Micro thruster, micro thruster array and polymer gas generator |
US20110269869A1 (en) * | 2006-12-13 | 2011-11-03 | Arturo Norberto Medina | Production of ophthalmic devices based on photo-induced step growth polymerization |
US20130245402A1 (en) * | 2012-03-13 | 2013-09-19 | Babak Ziaie | Sensor having ferrogel with magnetic particles |
US9238102B2 (en) | 2009-09-10 | 2016-01-19 | Medipacs, Inc. | Low profile actuator and improved method of caregiver controlled administration of therapeutics |
US9400277B2 (en) | 2004-07-19 | 2016-07-26 | ProteinSimple | Methods and devices for analyte detection |
US9500186B2 (en) | 2010-02-01 | 2016-11-22 | Medipacs, Inc. | High surface area polymer actuator with gas mitigating components |
US9766206B2 (en) | 2013-09-27 | 2017-09-19 | ProteinSimple | Apparatus, systems, and methods for capillary electrophoresis |
US9804079B2 (en) | 2012-04-19 | 2017-10-31 | ProteinSimple | Dual wavelength isoelectric focusing for determining drug load in antibody drug conjugates |
US9995295B2 (en) | 2007-12-03 | 2018-06-12 | Medipacs, Inc. | Fluid metering device |
US10000605B2 (en) | 2012-03-14 | 2018-06-19 | Medipacs, Inc. | Smart polymer materials with excess reactive molecules |
US9999369B2 (en) | 2012-03-13 | 2018-06-19 | Purdue Research Foundation | Laser-scribed ferrogel sensor with magnetic particles |
US10107782B2 (en) | 2008-01-25 | 2018-10-23 | ProteinSimple | Method to perform limited two dimensional separation of proteins and other biologicals |
Families Citing this family (149)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6465178B2 (en) * | 1997-09-30 | 2002-10-15 | Surmodics, Inc. | Target molecule attachment to surfaces |
US6762019B2 (en) * | 1997-09-30 | 2004-07-13 | Surmodics, Inc. | Epoxide polymer surfaces |
US6391937B1 (en) * | 1998-11-25 | 2002-05-21 | Motorola, Inc. | Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers |
EP1157270A1 (en) * | 1999-02-03 | 2001-11-28 | Aclara BioSciences, Inc. | Multichannel control in microfluidics |
US7638464B2 (en) | 1999-04-26 | 2009-12-29 | Biocept, Inc. | Three dimensional format biochips |
US20030096265A1 (en) * | 1999-06-25 | 2003-05-22 | Motorola, Inc. | Phosphoramidites for coupling oligonucleotides to [2 + 2] photoreactive groups |
US6921638B2 (en) | 1999-06-25 | 2005-07-26 | Amersham Biosciences Ab | Hydrogel-based microarray signal amplification methods and devices therefor |
US6664061B2 (en) | 1999-06-25 | 2003-12-16 | Amersham Biosciences Ab | Use and evaluation of a [2+2] photoaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix |
AU7708500A (en) * | 1999-09-22 | 2001-04-24 | Ge Healthcare Bio-Sciences Ab | Three-dimensional microarray system for parallel genotyping of single nucleotide polymorphisms |
US7186419B2 (en) | 2000-08-25 | 2007-03-06 | Contura Sa | Polyacrylamide hydrogel for arthritis |
MY130475A (en) | 2000-08-25 | 2007-06-29 | Contura As | Polyacrylamide hydrogel and its use as an endoprosthesis |
KR20020089315A (en) * | 2000-10-26 | 2002-11-29 | 바이오셉트 인코포레이티드 | Three dimensional format biochips |
WO2003018078A1 (en) * | 2001-08-31 | 2003-03-06 | Mihai Curtescu | Curable compositions containing polymeric hydrogels and process for manufacturing technical articles and staples products therefrom |
AU2002353997A1 (en) * | 2001-11-01 | 2003-05-12 | Rensselaer Polytechnic Institute | In vitro metabolic engineering on microscale devices |
US7445894B2 (en) * | 2002-05-03 | 2008-11-04 | Molecular Probes, Inc. | Compositions and methods for detection and isolation of phosphorylated molecules |
US7102005B2 (en) * | 2002-05-03 | 2006-09-05 | Molecular Probes, Inc. | Compositions and methods for detection and isolation of phosphorylated molecules |
US20040171034A1 (en) * | 2002-05-03 | 2004-09-02 | Brian Agnew | Compositions and methods for detection and isolation of phosphorylated molecules |
US20060111517A1 (en) * | 2002-08-08 | 2006-05-25 | Hans-Dieter Feucht | Recognition layers made of hydrogel based on polyacrylamide for use in biosensor technology |
DE10236460A1 (en) * | 2002-08-08 | 2004-02-26 | Siemens Ag | Liquid composition for producing photostructured polyacrylamide hydrogel layers, e.g. on transducers, comprises a film former, a comonomer with reactive linker groups, and a plasticizer |
EP1527203B1 (en) * | 2002-08-08 | 2007-04-18 | Siemens Aktiengesellschaft | Radically crosslinkable hydrogel comprising linker groups |
US8389700B2 (en) * | 2002-09-23 | 2013-03-05 | Alcatel Lucent | Agent delivery system capable of selectively releasing an agent |
US7919600B2 (en) * | 2002-09-23 | 2011-04-05 | Alcatel-Lucent Usa Inc. | Compositions that reversibly gel and de-gel |
JP4773348B2 (en) | 2003-07-12 | 2011-09-14 | アクセラー8 テクノロジー コーポレイション | Sensitive and rapid biodetection method |
US20120077206A1 (en) | 2003-07-12 | 2012-03-29 | Accelr8 Technology Corporation | Rapid Microbial Detection and Antimicrobial Susceptibility Testing |
DE10358565B4 (en) * | 2003-12-15 | 2007-06-28 | P.A.L.M. Microlaser Technologies Ag | A receiving element for receiving an object released from a biological mass by means of laser radiation and method for obtaining and processing a biological object |
WO2005065814A1 (en) | 2004-01-07 | 2005-07-21 | Solexa Limited | Modified molecular arrays |
US7026851B2 (en) * | 2004-05-12 | 2006-04-11 | System General Corp. | PWM controller having frequency jitter for power supplies |
JP2008520781A (en) * | 2004-11-22 | 2008-06-19 | ノバルティス アクチエンゲゼルシャフト | Crosslinkable poly (oxyalkylene) -containing polyamide prepolymer |
US20060138079A1 (en) * | 2004-12-27 | 2006-06-29 | Potyrailo Radislav A | Fabrication process of microfluidic devices |
US20060257560A1 (en) * | 2004-12-30 | 2006-11-16 | Affymetrix, Inc. | Polymer surfaces for insitu synthesis of polymer arrays |
US20060276560A1 (en) * | 2005-06-07 | 2006-12-07 | Sivapackia Ganapathiappan | Polymer precursor and method of making the same |
GB0514936D0 (en) | 2005-07-20 | 2005-08-24 | Solexa Ltd | Preparation of templates for nucleic acid sequencing |
US20080132429A1 (en) * | 2006-05-23 | 2008-06-05 | Uchicago Argonne | Biological microarrays with enhanced signal yield |
US8163154B1 (en) | 2006-09-29 | 2012-04-24 | Sandia Corporation | Method for voltage-gated protein fractionation |
US7989396B2 (en) * | 2006-12-05 | 2011-08-02 | The Board Of Trustees Of The Leland Stanford Junior University | Biomolecule immobilization on biosensors |
EP2277027A1 (en) * | 2008-04-16 | 2011-01-26 | Smart Holograms Limited | Photopolymerizable compositions |
US8734890B2 (en) * | 2009-09-16 | 2014-05-27 | National Tsing Hua University | Method for forming a molecularly imprinted polymer biosensor |
US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US20190300945A1 (en) | 2010-04-05 | 2019-10-03 | Prognosys Biosciences, Inc. | Spatially Encoded Biological Assays |
JP5893607B2 (en) | 2010-04-05 | 2016-03-23 | プログノシス バイオサイエンシズ インコーポレイテッドPrognosys Biosciences,Inc. | Spatial-encoded biological assay |
US10254204B2 (en) | 2011-03-07 | 2019-04-09 | Accelerate Diagnostics, Inc. | Membrane-assisted purification |
ES2551922T3 (en) | 2011-03-07 | 2015-11-24 | Accelerate Diagnostics, Inc. | Rapid cell purification systems |
GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
WO2012170936A2 (en) | 2011-06-09 | 2012-12-13 | Illumina, Inc. | Patterned flow-cells useful for nucleic acid analysis |
US20130096029A1 (en) * | 2011-09-06 | 2013-04-18 | The Trustees Of Columbia University In The City Of New York | Multiplexed in vivo screening of biological samples |
WO2013063382A2 (en) | 2011-10-28 | 2013-05-02 | Illumina, Inc. | Microarray fabrication system and method |
EP2776165A2 (en) | 2011-11-07 | 2014-09-17 | Illumina, Inc. | Integrated sequencing apparatuses and methods of use |
US9012022B2 (en) | 2012-06-08 | 2015-04-21 | Illumina, Inc. | Polymer coatings |
US9512422B2 (en) | 2013-02-26 | 2016-12-06 | Illumina, Inc. | Gel patterned surfaces |
CN105164106B (en) | 2013-03-08 | 2018-04-03 | 伊鲁米纳剑桥有限公司 | Polymethine compound and its purposes as fluorescent marker |
CN105263918B (en) | 2013-03-08 | 2018-05-18 | 伊鲁米纳剑桥有限公司 | Rhodamine compound and its purposes as fluorescent marker |
US9677109B2 (en) | 2013-03-15 | 2017-06-13 | Accelerate Diagnostics, Inc. | Rapid determination of microbial growth and antimicrobial susceptibility |
WO2014210225A1 (en) | 2013-06-25 | 2014-12-31 | Prognosys Biosciences, Inc. | Methods and systems for determining spatial patterns of biological targets in a sample |
PL3017065T3 (en) | 2013-07-01 | 2019-03-29 | Illumina, Inc. | Catalyst-free surface functionalization and polymer grafting |
US10215753B2 (en) * | 2013-08-05 | 2019-02-26 | University Of Rochester | Method for the topographically-selective passivation of micro- and nanoscale devices |
US10800931B2 (en) * | 2013-08-25 | 2020-10-13 | Heraeus Medical Components Llc | Conductive polymeric coatings, medical devices, coating solutions and methods |
US20170158836A1 (en) * | 2013-11-25 | 2017-06-08 | Carnegie Mellon University | Ordered macroporous hydrogels for bioresponsive processes |
CN114089597A (en) | 2013-12-19 | 2022-02-25 | Illumina公司 | Substrate comprising a nanopatterned surface and method for the production thereof |
WO2015103225A1 (en) | 2013-12-31 | 2015-07-09 | Illumina, Inc. | Addressable flow cell using patterned electrodes |
GB201408077D0 (en) | 2014-05-07 | 2014-06-18 | Illumina Cambridge Ltd | Polymethine compounds and their use as fluorescent labels |
US9360759B2 (en) | 2014-09-12 | 2016-06-07 | Eastman Kodak Company | Forming conductive metal patterns using water-soluble polymers |
KR20170132856A (en) | 2015-03-30 | 2017-12-04 | 액셀러레이트 다이어그노스틱스, 아이엔씨. | Instruments and systems for rapid microbiological identification and antimicrobial susceptibility testing |
US10253355B2 (en) | 2015-03-30 | 2019-04-09 | Accelerate Diagnostics, Inc. | Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing |
US10774374B2 (en) | 2015-04-10 | 2020-09-15 | Spatial Transcriptomics AB and Illumina, Inc. | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
GB201508858D0 (en) | 2015-05-22 | 2015-07-01 | Illumina Cambridge Ltd | Polymethine compounds with long stokes shifts and their use as fluorescent labels |
US20180207920A1 (en) | 2015-07-17 | 2018-07-26 | Illumina, Inc. | Polymer sheets for sequencing applications |
US10725382B2 (en) | 2015-09-04 | 2020-07-28 | Saint Louis University | Custom multiwell plate design for rapid assembly of photo-patterned hydrogels |
GB201516987D0 (en) | 2015-09-25 | 2015-11-11 | Illumina Cambridge Ltd | Polymethine compounds and their use as fluorescent labels |
WO2017175200A1 (en) | 2016-04-08 | 2017-10-12 | The Regents Of The University Of California | Modified hyaluronic acid hydrogels and proteins for the time-controlled release of biologic agents |
KR102171865B1 (en) | 2016-05-18 | 2020-10-29 | 일루미나, 인코포레이티드 | Self-assembled patterning using patterned hydrophobic surfaces |
US10385214B2 (en) | 2016-09-30 | 2019-08-20 | Illumina Cambridge Limited | Fluorescent dyes and their uses as biomarkers |
FI3522713T3 (en) | 2016-10-03 | 2023-01-13 | Fluorescent detection of amines and hydrazines and assaying methods thereof | |
CN109476674B (en) | 2016-12-22 | 2021-12-10 | 伊鲁米纳剑桥有限公司 | Coumarin compound and application thereof as fluorescent marker |
US10955332B2 (en) | 2016-12-22 | 2021-03-23 | Illumina, Inc. | Flow cell package and method for making the same |
EP3559262A4 (en) | 2016-12-22 | 2020-07-22 | Illumina, Inc. | Arrays with quality control tracers |
RU2765075C2 (en) | 2016-12-22 | 2022-01-25 | Иллюмина, Инк. | Biochip including sequencing primer and non-sequencing unit |
WO2018118932A1 (en) | 2016-12-22 | 2018-06-28 | Illumina, Inc. | Imprinting apparatus |
KR102512186B1 (en) | 2016-12-22 | 2023-03-20 | 일루미나, 인코포레이티드 | Array comprising a resin film and a patterned polymer layer |
GB201711219D0 (en) | 2017-07-12 | 2017-08-23 | Illumina Cambridge Ltd | Short pendant arm linkers for nucleotides in sequencing applications |
GB201716931D0 (en) | 2017-10-16 | 2017-11-29 | Illumina Cambridge Ltd | New fluorescent compounds and their use as biomarkers |
CN108409906B (en) * | 2018-03-16 | 2019-06-07 | 福州大学 | A kind of ionic hydrogels and preparation method thereof of alternative absorption bovine serum albumin |
US20230323447A1 (en) | 2018-08-28 | 2023-10-12 | 10X Genomics, Inc. | Method for transposase-mediated spatial tagging and analyzing genomic dna in a biological sample |
US11519033B2 (en) | 2018-08-28 | 2022-12-06 | 10X Genomics, Inc. | Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample |
EP3844308A1 (en) | 2018-08-28 | 2021-07-07 | 10X Genomics, Inc. | Resolving spatial arrays |
WO2020123316A2 (en) | 2018-12-10 | 2020-06-18 | 10X Genomics, Inc. | Methods for determining a location of a biological analyte in a biological sample |
US11293061B2 (en) | 2018-12-26 | 2022-04-05 | Illumina Cambridge Limited | Sequencing methods using nucleotides with 3′ AOM blocking group |
US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
CN114174531A (en) | 2019-02-28 | 2022-03-11 | 10X基因组学有限公司 | Profiling of biological analytes with spatially barcoded oligonucleotide arrays |
WO2020178231A1 (en) | 2019-03-01 | 2020-09-10 | Illumina, Inc. | Multiplexed fluorescent detection of analytes |
NL2023327B1 (en) | 2019-03-01 | 2020-09-17 | Illumina Inc | Multiplexed fluorescent detection of analytes |
SG11202012555UA (en) | 2019-03-01 | 2021-01-28 | Illumina Cambridge Ltd | Exocyclic amine-substituted coumarin compounds and their uses as fluorescent labels |
US20200277670A1 (en) | 2019-03-01 | 2020-09-03 | Illumina Cambridge Limited | Tertiary amine substituted coumarin compounds and uses as fluorescent labels |
WO2020190509A1 (en) | 2019-03-15 | 2020-09-24 | 10X Genomics, Inc. | Methods for using spatial arrays for single cell sequencing |
WO2020198071A1 (en) | 2019-03-22 | 2020-10-01 | 10X Genomics, Inc. | Three-dimensional spatial analysis |
US11421271B2 (en) | 2019-03-28 | 2022-08-23 | Illumina Cambridge Limited | Methods and compositions for nucleic acid sequencing using photoswitchable labels |
WO2020219901A1 (en) | 2019-04-26 | 2020-10-29 | 10X Genomics, Inc. | Imaging support devices |
CN117036248A (en) | 2019-10-01 | 2023-11-10 | 10X基因组学有限公司 | System and method for identifying morphological patterns in tissue samples |
EP4055185A1 (en) | 2019-11-08 | 2022-09-14 | 10X Genomics, Inc. | Spatially-tagged analyte capture agents for analyte multiplexing |
WO2021097255A1 (en) | 2019-11-13 | 2021-05-20 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
AU2020388047A1 (en) | 2019-11-18 | 2022-06-23 | 10X Genomics, Inc. | Systems and methods for tissue classification |
CN117078725A (en) | 2019-11-21 | 2023-11-17 | 10X基因组学有限公司 | Spatial analysis of analytes |
WO2021102005A1 (en) | 2019-11-22 | 2021-05-27 | 10X Genomics, Inc. | Systems and methods for spatial analysis of analytes using fiducial alignment |
JP2023510454A (en) | 2019-11-27 | 2023-03-14 | イルミナ ケンブリッジ リミテッド | Pigments and compositions containing cyclooctatetraene |
US11821035B1 (en) | 2020-01-29 | 2023-11-21 | 10X Genomics, Inc. | Compositions and methods of making gene expression libraries |
US20210254140A1 (en) | 2020-02-17 | 2021-08-19 | 10X Genomics, Inc. | Situ analysis of chromatin interaction |
JP2023514749A (en) | 2020-02-21 | 2023-04-07 | 10エックス ジェノミクス インコーポレイテッド | Methods and compositions for integrated in situ spatial assays |
CA3177293A1 (en) | 2020-06-22 | 2021-12-30 | Illumina Cambridge Limited | Nucleosides and nucleotides with 3' acetal blocking group |
US20220033900A1 (en) | 2020-07-28 | 2022-02-03 | Illumina Cambridge Limited | Substituted coumarin dyes and uses as fluorescent labels |
WO2022098810A1 (en) | 2020-11-06 | 2022-05-12 | 10X Genomics, Inc. | Assay support devices |
US20220186300A1 (en) | 2020-12-11 | 2022-06-16 | 10X Genomics, Inc. | Methods and compositions for multimodal in situ analysis |
US20220195516A1 (en) | 2020-12-17 | 2022-06-23 | Illumina Cambridge Limited | Methods, systems and compositions for nucleic acid sequencing |
US20220195518A1 (en) | 2020-12-22 | 2022-06-23 | Illumina Cambridge Limited | Methods and compositions for nucleic acid sequencing |
EP4267760A1 (en) | 2020-12-23 | 2023-11-01 | 10X Genomics, Inc. | Methods and compositions for analyte detection |
CN112898925A (en) * | 2021-01-25 | 2021-06-04 | 义乌市鹏之友新材料研究所有限公司 | Adhesive and preparation method and application thereof |
CN116724125A (en) | 2021-01-26 | 2023-09-08 | 10X基因组学有限公司 | Nucleic acid analogue probes for in situ analysis |
EP4294571A2 (en) | 2021-02-19 | 2023-12-27 | 10X Genomics, Inc. | Modular assay support devices |
WO2022187366A1 (en) | 2021-03-03 | 2022-09-09 | 10X Genomics, Inc. | Analyte detection in situ using nucleic acid origami |
CN113129732B (en) * | 2021-04-18 | 2022-11-11 | 桂林理工大学 | Technology for applying acrylic acid-acrylamide copolymer to time resolution information encryption |
EP4341434A1 (en) | 2021-05-20 | 2024-03-27 | Illumina, Inc. | Compositions and methods for sequencing by synthesis |
WO2022256324A1 (en) | 2021-06-01 | 2022-12-08 | 10X Genomics, Inc. | Methods and compositions for analyte detection and probe resolution |
CN117751197A (en) | 2021-06-02 | 2024-03-22 | 10X基因组学有限公司 | Sample analysis using asymmetric circularizable probes |
US20230012607A1 (en) | 2021-07-09 | 2023-01-19 | 10X Genomics, Inc. | Methods for detecting analytes using sparse labelling |
US20230026886A1 (en) | 2021-07-13 | 2023-01-26 | 10X Genomics, Inc. | Methods for preparing polymerized matrix with controllable thickness |
CN113662911A (en) * | 2021-08-02 | 2021-11-19 | 郑州大学第一附属医院 | High-adhesion pain-relieving hydrogel patch and preparation method thereof |
WO2023015192A1 (en) | 2021-08-03 | 2023-02-09 | 10X Genomics, Inc. | Nucleic acid concatemers and methods for stabilizing and/or compacting the same |
US20230061542A1 (en) | 2021-08-16 | 2023-03-02 | 10X Genomics, Inc. | Probes comprising a split barcode region and methods of use |
WO2023076580A1 (en) * | 2021-10-29 | 2023-05-04 | Georgia Tech Research Corporation | Hydrogel structures and methods of making and use thereof |
AU2022413575A1 (en) | 2021-12-16 | 2024-01-18 | Illumina, Inc. | Methods for metal directed cleavage of surface-bound polynucleotides |
CN117813399A (en) | 2021-12-20 | 2024-04-02 | 因美纳有限公司 | Periodate compositions and methods for chemically cleaving surface-bound polynucleotides |
CA3223274A1 (en) | 2021-12-20 | 2023-06-29 | Illumina, Inc. | Periodate compositions and methods for chemical cleavage of surface-bound polynucleotides |
US20230242974A1 (en) | 2021-12-27 | 2023-08-03 | 10X Genomics, Inc. | Methods and compositions for rolling circle amplification |
US20230279475A1 (en) | 2022-01-21 | 2023-09-07 | 10X Genomics, Inc. | Multiple readout signals for analyzing a sample |
US20230304086A1 (en) | 2022-03-28 | 2023-09-28 | Illumina Cambridge Limited | Labeled avidin and methods for sequencing |
CA3223125A1 (en) | 2022-03-29 | 2023-10-05 | Illumina, Inc. | Chromenoquinoline dyes and uses in sequencing |
CA3223037A1 (en) | 2022-03-30 | 2023-10-05 | Oliver MILLER | Methods for chemical cleavage of surface-bound polynucleotides |
US20230357845A1 (en) | 2022-03-31 | 2023-11-09 | Illumina, Inc. | Compositions and methods for improving sequencing signals |
CA3222797A1 (en) | 2022-03-31 | 2023-10-05 | Ramesh NEELAKANDAN | Nucleosides and nucleotides with 3' vinyl blocking group |
WO2023192616A1 (en) | 2022-04-01 | 2023-10-05 | 10X Genomics, Inc. | Compositions and methods for targeted masking of autofluorescence |
US20230323427A1 (en) | 2022-04-06 | 2023-10-12 | 10X Genomics, Inc. | Methods and compositions for multiplex cell analysis |
WO2023215612A1 (en) | 2022-05-06 | 2023-11-09 | 10X Genomics, Inc. | Analysis of antigen and antigen receptor interactions |
WO2023215603A1 (en) | 2022-05-06 | 2023-11-09 | 10X Genomics, Inc. | Methods and compositions for in situ analysis of v(d)j sequences |
WO2023220300A1 (en) | 2022-05-11 | 2023-11-16 | 10X Genomics, Inc. | Compositions and methods for in situ sequencing |
WO2023232829A1 (en) | 2022-05-31 | 2023-12-07 | Illumina, Inc | Compositions and methods for nucleic acid sequencing |
US20240035071A1 (en) | 2022-06-17 | 2024-02-01 | 10X Genomics, Inc. | Catalytic de-crosslinking of samples for in situ analysis |
CN115120772B (en) * | 2022-06-20 | 2023-01-17 | 北京科技大学 | Multifunctional DNA hydrogel integration dressing for maintaining dryness of stem cells and preparation method thereof |
US20230416279A1 (en) | 2022-06-28 | 2023-12-28 | Illumina Cambridge Limited | Fluorescent dyes containing fused tetracyclic bis-boron heterocycle and uses in sequencing |
WO2024039516A1 (en) | 2022-08-19 | 2024-02-22 | Illumina, Inc. | Third dna base pair site-specific dna detection |
WO2024068889A2 (en) | 2022-09-30 | 2024-04-04 | Illumina, Inc. | Compositions and methods for reducing photo damage during sequencing |
Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4719615A (en) * | 1983-08-22 | 1988-01-12 | Optical Data, Inc. | Erasable optical data storage medium |
US5001243A (en) * | 1988-05-27 | 1991-03-19 | Ciba-Geigy Corporation | Substituted naphthacene-5, 12-diones |
US5002582A (en) * | 1982-09-29 | 1991-03-26 | Bio-Metric Systems, Inc. | Preparation of polymeric surfaces via covalently attaching polymers |
US5489623A (en) * | 1992-12-24 | 1996-02-06 | The Dow Chemical Company | Photodefinable polymers containing perfluorocyclobutane groups |
US5552270A (en) * | 1991-03-18 | 1996-09-03 | Institut Molekulyarnoi Biologii Imeni V.A. | Methods of DNA sequencing by hybridization based on optimizing concentration of matrix-bound oligonucleotide and device for carrying out same |
US5736257A (en) * | 1995-04-25 | 1998-04-07 | Us Navy | Photoactivatable polymers for producing patterned biomolecular assemblies |
US5741700A (en) * | 1993-08-11 | 1998-04-21 | University Of Chicago | Method of immobilizing water-soluble bioorganic compounds on a capillary-porous carrier |
US5756050A (en) * | 1993-08-11 | 1998-05-26 | University Of Chicago | Device of dispensing micro doses of aqueous solutions of substances onto a carrier and device for carrying out said method |
US5770721A (en) * | 1993-08-11 | 1998-06-23 | University Of Chicago | Method of manufacturing a matrix for the detection of mismatches |
US5922473A (en) * | 1996-12-26 | 1999-07-13 | Morton International, Inc. | Dual thermal and ultraviolet curable powder coatings |
US5942555A (en) * | 1996-03-21 | 1999-08-24 | Surmodics, Inc. | Photoactivatable chain transfer agents and semi-telechelic photoactivatable polymers prepared therefrom |
US5962578A (en) * | 1997-11-19 | 1999-10-05 | Amcol International Corporation | Poly(dialkylaminoalkyl (meth)acrylamide)-based superabsorbent gels |
US5990193A (en) * | 1995-12-12 | 1999-11-23 | University Of Pittsburgh | Polymers for reversible photoinduced sol gel transitions |
US6007833A (en) * | 1998-03-19 | 1999-12-28 | Surmodics, Inc. | Crosslinkable macromers bearing initiator groups |
USRE36625E (en) * | 1993-02-17 | 2000-03-21 | Rolic Ag | Linear and cyclic polymers or oligomers having a photoreactive ethene group |
US6294591B1 (en) * | 1996-12-20 | 2001-09-25 | Basf Coatings Ag | Method for producing polymers cross-linkable by radiation, acrylic or methacrylic acid esters |
US6391937B1 (en) * | 1998-11-25 | 2002-05-21 | Motorola, Inc. | Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8530715D0 (en) | 1985-12-13 | 1986-01-22 | Unilever Plc | Microchemical testing |
US5292821A (en) | 1988-12-28 | 1994-03-08 | Mitsui Toatsu Chemicals, Inc. | Catonic acrylamide polymers and the applications of these polymers |
WO1991007087A1 (en) | 1989-11-13 | 1991-05-30 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
DE69120042T2 (en) | 1990-11-28 | 1996-10-17 | Dai Ichi Kogyo Seiyaku Co Ltd | N-substituted acrylamide copolymers |
CA2091489C (en) | 1992-04-13 | 2001-05-08 | Ahmad Moradi-Araghi | Gelation of water soluble polymers |
US5861247A (en) | 1996-01-26 | 1999-01-19 | University Of Chicago | Rapid method to detect duplex formation in sequencing by hybridization methods |
US5905024A (en) | 1996-12-17 | 1999-05-18 | University Of Chicago | Method for performing site-specific affinity fractionation for use in DNA sequencing |
WO1998028444A2 (en) | 1996-12-23 | 1998-07-02 | The University Of Chicago | Customized oligonucleotide microchips as multiple biosensors |
-
1999
- 1999-06-25 US US09/344,217 patent/US6391937B1/en not_active Expired - Fee Related
- 1999-11-23 WO PCT/US1999/027783 patent/WO2000031148A2/en active Application Filing
- 1999-11-23 AU AU20285/00A patent/AU2028500A/en not_active Abandoned
-
2002
- 2002-04-23 US US10/131,426 patent/US20020115740A1/en not_active Abandoned
Patent Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5002582A (en) * | 1982-09-29 | 1991-03-26 | Bio-Metric Systems, Inc. | Preparation of polymeric surfaces via covalently attaching polymers |
US4719615A (en) * | 1983-08-22 | 1988-01-12 | Optical Data, Inc. | Erasable optical data storage medium |
US5001243A (en) * | 1988-05-27 | 1991-03-19 | Ciba-Geigy Corporation | Substituted naphthacene-5, 12-diones |
US5552270A (en) * | 1991-03-18 | 1996-09-03 | Institut Molekulyarnoi Biologii Imeni V.A. | Methods of DNA sequencing by hybridization based on optimizing concentration of matrix-bound oligonucleotide and device for carrying out same |
US5489623A (en) * | 1992-12-24 | 1996-02-06 | The Dow Chemical Company | Photodefinable polymers containing perfluorocyclobutane groups |
USRE36625E (en) * | 1993-02-17 | 2000-03-21 | Rolic Ag | Linear and cyclic polymers or oligomers having a photoreactive ethene group |
US5770721A (en) * | 1993-08-11 | 1998-06-23 | University Of Chicago | Method of manufacturing a matrix for the detection of mismatches |
US5756050A (en) * | 1993-08-11 | 1998-05-26 | University Of Chicago | Device of dispensing micro doses of aqueous solutions of substances onto a carrier and device for carrying out said method |
US5741700A (en) * | 1993-08-11 | 1998-04-21 | University Of Chicago | Method of immobilizing water-soluble bioorganic compounds on a capillary-porous carrier |
US5736257A (en) * | 1995-04-25 | 1998-04-07 | Us Navy | Photoactivatable polymers for producing patterned biomolecular assemblies |
US5990193A (en) * | 1995-12-12 | 1999-11-23 | University Of Pittsburgh | Polymers for reversible photoinduced sol gel transitions |
US5942555A (en) * | 1996-03-21 | 1999-08-24 | Surmodics, Inc. | Photoactivatable chain transfer agents and semi-telechelic photoactivatable polymers prepared therefrom |
US6294591B1 (en) * | 1996-12-20 | 2001-09-25 | Basf Coatings Ag | Method for producing polymers cross-linkable by radiation, acrylic or methacrylic acid esters |
US5922473A (en) * | 1996-12-26 | 1999-07-13 | Morton International, Inc. | Dual thermal and ultraviolet curable powder coatings |
US5962578A (en) * | 1997-11-19 | 1999-10-05 | Amcol International Corporation | Poly(dialkylaminoalkyl (meth)acrylamide)-based superabsorbent gels |
US6007833A (en) * | 1998-03-19 | 1999-12-28 | Surmodics, Inc. | Crosslinkable macromers bearing initiator groups |
US6391937B1 (en) * | 1998-11-25 | 2002-05-21 | Motorola, Inc. | Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers |
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6686161B2 (en) * | 1999-06-25 | 2004-02-03 | Amersham Biosciences Ab | Methods and compositions for attachment of biomolecules to solid supports, hydrogels, and hydrogel arrays |
US8809071B2 (en) * | 2002-11-29 | 2014-08-19 | Marcella Chiari | Method for immobilizing biologic molecules on solid surfaces |
US20060141464A1 (en) * | 2002-11-29 | 2006-06-29 | Marcella Chiari | Method for immobilizing biologic molecules on solid surfaces |
US9834617B2 (en) | 2002-11-29 | 2017-12-05 | Marcella Chiari | Method for immobilizing biologic molecules on solid surfaces |
US9400277B2 (en) | 2004-07-19 | 2016-07-26 | ProteinSimple | Methods and devices for analyte detection |
US9304133B2 (en) * | 2004-07-19 | 2016-04-05 | ProteinSimple | Methods and devices for analyte detection |
US20110195527A1 (en) * | 2004-07-19 | 2011-08-11 | Cell Biosciences, Inc. | Methods and devices for analyte detection |
US20070062813A1 (en) * | 2005-09-20 | 2007-03-22 | Erik Gentalen | Electrophoresis standards, methods and kits |
US8945361B2 (en) | 2005-09-20 | 2015-02-03 | ProteinSimple | Electrophoresis standards, methods and kits |
US20110198004A1 (en) * | 2005-10-20 | 2011-08-18 | Mark Banister | Micro thruster, micro thruster array and polymer gas generator |
US20100285094A1 (en) * | 2006-04-20 | 2010-11-11 | University Of Utah Research Foundation | Polymeric compositions and methods of making and using thereof |
US20090317442A1 (en) * | 2006-07-10 | 2009-12-24 | Medipacs, Inc. | Super Elastic Epoxy Hydrogel |
US10208158B2 (en) * | 2006-07-10 | 2019-02-19 | Medipacs, Inc. | Super elastic epoxy hydrogel |
US8609745B2 (en) | 2006-12-13 | 2013-12-17 | Novartis Ag | Production of ophthalmic devices based on photo-induced step growth polymerization |
US8357771B2 (en) * | 2006-12-13 | 2013-01-22 | Novartis Ag | Production of ophthalmic devices based on photo-induced step growth polymerization |
US20110269869A1 (en) * | 2006-12-13 | 2011-11-03 | Arturo Norberto Medina | Production of ophthalmic devices based on photo-induced step growth polymerization |
US9995295B2 (en) | 2007-12-03 | 2018-06-12 | Medipacs, Inc. | Fluid metering device |
US10107782B2 (en) | 2008-01-25 | 2018-10-23 | ProteinSimple | Method to perform limited two dimensional separation of proteins and other biologicals |
WO2010005290A1 (en) * | 2008-07-11 | 2010-01-14 | Parvus Beheer B.V. | Method for the preparation of a biocompatible hydrogel |
US9238102B2 (en) | 2009-09-10 | 2016-01-19 | Medipacs, Inc. | Low profile actuator and improved method of caregiver controlled administration of therapeutics |
US9500186B2 (en) | 2010-02-01 | 2016-11-22 | Medipacs, Inc. | High surface area polymer actuator with gas mitigating components |
US9737244B2 (en) * | 2012-03-13 | 2017-08-22 | Purdue Research Foundation | Sensor having ferrogel with magnetic particles |
US9999369B2 (en) | 2012-03-13 | 2018-06-19 | Purdue Research Foundation | Laser-scribed ferrogel sensor with magnetic particles |
US20130245402A1 (en) * | 2012-03-13 | 2013-09-19 | Babak Ziaie | Sensor having ferrogel with magnetic particles |
US10000605B2 (en) | 2012-03-14 | 2018-06-19 | Medipacs, Inc. | Smart polymer materials with excess reactive molecules |
US9804079B2 (en) | 2012-04-19 | 2017-10-31 | ProteinSimple | Dual wavelength isoelectric focusing for determining drug load in antibody drug conjugates |
US10753859B2 (en) | 2012-04-19 | 2020-08-25 | ProteinSimple | Dual wavelength isoelectric focusing for determining drug load in antibody drug conjugates |
US9766206B2 (en) | 2013-09-27 | 2017-09-19 | ProteinSimple | Apparatus, systems, and methods for capillary electrophoresis |
US11933759B2 (en) | 2013-09-27 | 2024-03-19 | ProteinSimple | Apparatus, systems, and methods for capillary electrophoresis |
Also Published As
Publication number | Publication date |
---|---|
AU2028500A (en) | 2000-06-13 |
US20020035167A1 (en) | 2002-03-21 |
WO2000031148A2 (en) | 2000-06-02 |
WO2000031148A3 (en) | 2000-08-17 |
US6391937B1 (en) | 2002-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20020115740A1 (en) | Hydrogels and hydrogel arrays made from reactive prepolymers crosslinked by [2 + 2] cycloaddition | |
US6372813B1 (en) | Methods and compositions for attachment of biomolecules to solid supports, hydrogels, and hydrogel arrays | |
US6664061B2 (en) | Use and evaluation of a [2+2] photoaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix | |
JP3476196B2 (en) | Polymerizable composition and use thereof | |
JP4350906B2 (en) | Photo-curable and photo-patternable hydrogel matrix based on azlactone copolymer | |
US8664003B2 (en) | Chip provided with film having hole pattern with the use of thermoresponsive polymer and method of producing the same | |
US20090069198A1 (en) | Biomolecular Attachment Sites on Microelectronic Arrays and Methods Thereof | |
WO2002012566A2 (en) | The use and evaluation of a [2+2] photocycloaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix | |
JPH0548270B2 (en) | ||
JP2006322709A (en) | Substance fixing substrate | |
US20080188618A1 (en) | Porous Acrylate Copolymer Films and Uses Therefor | |
JP2004505170A (en) | Surface-bound polyfunctional polymer networks for sensor chips | |
JP4205944B2 (en) | A method for large-scale production of patterned surfaces for biological binding | |
Ganesan et al. | Simple micropatterning of biomolecules on a diazoketo-functionalized photoresist | |
JP2006316010A (en) | Substance-fixing agent, method for fixing substance and substrate for fixing substance | |
US20060111517A1 (en) | Recognition layers made of hydrogel based on polyacrylamide for use in biosensor technology | |
JP3430796B2 (en) | Copolymer cumulative film having cross-linking group and resist material using the same | |
JP4113349B2 (en) | DNA chip and manufacturing method thereof | |
CA2417903A1 (en) | Replicable probe array | |
JP2007516442A (en) | Molecular stamp for printing biomolecules on a substrate | |
JPH0853520A (en) | New polymer and lipid membrane immobilizing agent | |
MXPA96005326A (en) | Polymerizable composition and use of the mi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MOTOROLA, INC., ILLINOIS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BEUHLER, ALLYSON;MCGOWEN, JOHN;REEL/FRAME:012842/0535;SIGNING DATES FROM 20020415 TO 20020418 |
|
AS | Assignment |
Owner name: AMERSHAM BIOSCIENCES AB, SWEDEN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MOTOROLA, INC.;REEL/FRAME:013323/0940 Effective date: 20020718 |
|
AS | Assignment |
Owner name: GE HEALTHCARE BIO-SCIENCES AB,SWEDEN Free format text: CHANGE OF NAME;ASSIGNORS:PHARMACIA FINE CHEMICALS AB;PHARMACIA LKB BIOTECHNOLOGY AB;PHARMACIA BIOTECH AB;AND OTHERS;SIGNING DATES FROM 19670125 TO 20011017;REEL/FRAME:017186/0644 Owner name: GE HEALTHCARE BIO-SCIENCES AB, SWEDEN Free format text: CHANGE OF NAME;ASSIGNORS:PHARMACIA FINE CHEMICALS AB;PHARMACIA LKB BIOTECHNOLOGY AB;PHARMACIA BIOTECH AB;AND OTHERS;SIGNING DATES FROM 19670125 TO 20011017;REEL/FRAME:017186/0644 Owner name: GE HEALTHCARE BIO-SCIENCES AB, SWEDEN Free format text: CHANGE OF NAME;ASSIGNORS:PHARMACIA FINE CHEMICALS AB;PHARMACIA LKB BIOTECHNOLOGY AB;PHARMACIA BIOTECH AB;AND OTHERS;REEL/FRAME:017186/0644;SIGNING DATES FROM 19670125 TO 20011017 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |